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“You can see them labouring to breathe, 
Just imagine you are fighting to take in air. 
It’s really painful for you the doctor, 
And worse still for the parents, who are looking at their child. 
You know you could prevent this, that’s what hurts. 
Sometimes, you reach a point where you can’t do anything. 
You just watch as the patient breathes away…” 
- Dr Violet Okaba Kayom, Mulago National Referral Hospital, Uganda 
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ABSTRACT 
Background: Pneumonia is the leading cause of infectious death in children under-five in sub-
Saharan Africa and Southeast Asia. Currently, the diagnostic criterion for pneumonia is based 
on increased respiratory rate (RR) in children with cough and/or difficulty breathing. Low 
oxygen saturation, usually measured using pulse oximeters, is an indication of severe 
pneumonia. Health workers report finding it difficult to accurately count the number of breaths 
and current RR counting aids are often difficult to use or unavailable. Improved RR counting 
aids and lower-cost pulse oximeters are now available but their suitability in these settings and 
for these populations are untested. 
Objective: The studies sought to identify and evaluate the most accurate, acceptable and user-
friendly respiratory rate counting devices and pulse oximeters for diagnosis of pneumonia 
symptoms and severity in children by frontline health workers in low-resource settings. 
Methods: Three sub-studies (I-III) were conducted among health workers, children under five 
and their caregivers, and national stakeholders. Sub-study I uses an explanatory qualitative 
approach with pile sorting and focus group discussions with frontline health workers and 
national stakeholders to explore their perspectives regarding the potential usability and 
scalability of seven pneumonia diagnostic aids. In sub-study II (a & b) four RR counters and 
five pulse oximeters were evaluated for performance by a cross-sectional sample of frontline 
health workers in hospital settings against reference standards in Cambodia, Ethiopia, South 
Sudan and Uganda. In sub-study III the same nine devices were evaluated using mixed methods 
for usability and acceptability in routine practice, over three months, in the four countries. 
Findings: Frontline health workers and national stakeholders’ universally valued device 
simplicity, affordability and sustainability. They prioritised different device characteristics 
according to their specific focus of work, with health workers focusing more on device 
acceptability and national stakeholders’ being less accepting of new technologies (Sub-study 
I). In sub-study IIa most CHWs managed to achieve a RR count with the four devices. The 
agreement with the reference standard was low for all; the mean difference of RR 
measurements or breaths per minute (bpm) from the reference standard for the four devices 
ranged from 0.5 bpm (95% CI -2.2 to 1.2) for the respirometer to 5.5 bpm (95% CI 3.2 to 7.8) 
for Rrate. Performance was consistently lower for young infants (0 to <2 months) than for older 
children (2 to ≤59 months). Agreement of RR classification into fast and normal breathing was 
moderate across all four devices, with Cohen’s Kappa statistics ranging from 0.41 (SE 0.04) to 
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0.49 (SE 0.05). In Sub-study IIb, although all five pulse oximeters tested in the field had 
performed well on a simulator (±2% SpO2 from the simulator), their performance was more 
varied when used on real children by frontline health workers. The handheld pulse oximeters 
had greater overall agreement with the reference standard, ranging from -0.6% SpO2 (95% CI 
-0.9, 0.4) to -3.0% SpO2 (95% CI -3.4, -2.6) than the finger-tip pulse oximeters, which ranged 
from -3.9% SpO2 (95% CI -4.4, -3.4) to -7.9% SpO2 (95% CI -8.6,-7.2). This was particularly 
pronounced in the younger children, where handheld devices had -0.7 SpO2 (95% CI -1.4, -
0.1) to -5.9 SpO2 (95% CI -6.9, -4.9) agreement, compared to fingertip devices, which had -
8.0 SpO2 (95% CI -9.4, -6.6) to -13.3 SpO2 (95% CI -15.1, -11.5) agreement. First level health 
facility workers had better agreement in classification of hypoxaemia with the reference 
standard (N=0.32; SE 0.05 to N=0.86; SE 0.07) for all five devices, when compared to CHWs 
(N=0.15; SE 0.02 to N=0.59; SE 0.03). In Sub-study III health workers reported being better 
supported by assisted RR counters, which provided more support than their standard practice 
ARI timer in counting and classifying RR in sick children under 5 in these settings. 
Conclusions: Frontline health workers were able to use the nine test devices to measure RR 
and oxygen saturation in children under 5, but with variable performance, and found it more 
difficult to get a successful measurement in younger children. Frontline health workers were 
better supported by assisted RR counters, such as Rrate and respirometer, compared to their 
standard practice diagnostic aid, MK2 ARI timer. Handheld pulse oximeters with multiple 
probes performed better than fingertip pulse oximeters, especially in younger children. The 
views of different stakeholder groups should be considered when looking to take these types 
of pneumonia diagnostic aids to scale. A consensus view on a robust research method and 
reference standard to evaluate future pneumonia diagnostic aids needs to be reached. While 
laboratory testing of new diagnostic aids can be valuable it should not replace field testing with 
frontline health workers in routine practice. Automated, easy to use, robust and affordable 
pneumonia diagnostics aids need to be developed and launched at scale to better support 
frontline health workers to address the high pneumonia burden in resource poor settings. 
Key words: pneumonia, CHWs, diagnostic aids, innovation, pulse oximeters 
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1 BACKGROUND 
1.1 PNEUMONIA EPIDEMIOLOGY, AETIOLOGY, PREVENTION AND 
CONTROL 
Pneumonia is the leading cause of post-neonatal death in children under-five years, accounting 
for an annual 944,000 deaths globally; 15% of all under-five mortality worldwide (see Fig.1). 
Sixty percent of these deaths occur in ten countries in South Asia and sub-Saharan Africa (2), 
most facing significant challenges in the provision of effective health care, diagnosis and 
treatment. Pneumonia deaths in children result mostly from late presentation to appropriate 
care providers, inappropriate treatment or unrecognised symptoms (3). Most cases of 
pneumonia could be prevented by better nutrition, environmental improvements and new 
vaccines (4). Even when caregivers may recognise rapid breathing in a coughing child, this 
may not always prompt them to seek care, resulting in delays and potential development of 
severe disease (3, 5, 6).  
 
 
Figure 1 Causes of childhood deaths (Source: WHO Global Health Observatory, 2016) 
 
The term pneumonia is usually used in the broader sense to refer to severe acute infections 
of the lungs by viral, bacterial, and other pathogens (4). Historically, Streptococcus 
pneumonia (pneumococcus) and Haemophilus influenza (usually type B or Hib) are the 
leading bacterial causes of pneumonia (7), and respiratory syncytial virus the leading viral 
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cause (4). Previous studies of the aetiology of childhood pneumonia in low income countries 
provided similar findings (8). However, the most recent evidence suggests that this is no 
longer the case, most probably due to the introduction of pneumococcal conjugate vaccine 
(PCV) and Hib vaccine, and highlights that it is now respiratory syncytial virus (RSV) that 
is the main cause of severe pneumonia (9).  
Pneumonia symptoms include sudden onset of cough, fever, fast and difficult breathing, 
vomiting, convulsions and chest in-drawing (4). Pneumonia is characterised by inflammation 
of the alveoli and terminal airspaces in response to invasion by an infectious agent introduced 
into the lungs. Pneumonia is responsible for stuffing the alveoli with fibrous sticky liquid 
hindering the exchange of oxygen and carbon dioxide in the blood, resulting in depleted 
oxygen levels, increased levels of CO2 and faster breathing in the affected individual. World 
Health Organisation (WHO) defines non-severe pneumonia as any child with cough or 
difficult breathing who has fast breathing and no general danger signs, no chest in-drawing 
and no stridor when calm (10).  
Effective vaccines against H. influenza b (Hib) are now widely available and continue to be 
rolled out in resource-poor settings, thereby reducing the total number of bacteria cases being 
seen. As there are more than 90 serotypes of pneumococcal bacteria, and the pneumococcal 
conjugate vaccine (PCV13) protects against only 13 of them, continued progress to further 
reduce pneumonia mortality is restricted by the absence of vaccines against the remaining 
required serotypes (11). Other protective and preventive measures, such as breastfeeding, 
measles vaccination and reducing indoor air pollution are equally important and recent 
studies have highlighted the need to adjust treatment algorithms to emphasise supportive care 
(9). Amoxicillin, an inexpensive antibiotic which can be administered at home, can 
effectively treat the majority of pneumonia in children in countries with high infant mortality 
of bacterial origin, mostly caused by Streptococcus pneumoniae or Haemophilus influenza 
(12). However, the efficient supply of drugs to frontline health workers has often be reported 
as a major issue in the effective case management of pneumonia in these settings (13).   
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1.2 CASE MANAGEMENT OF PNEUMONIA 
The WHO Acute Respiratory Infection (ARI) Technical Advisory Group in March 1982 defined 
that case management of pneumonia remained the central strategy to reduce significantly, at 
least in the short term, the ARI-associated mortality in young children in low income countries. 
The group recommended a simple protocol for discrimination of pneumonia in places where 
X-Ray technology was not available. The protocol was developed on the basis of field 
investigations by Shann et al at the WHO Collaborating Centre in Papua New Guinea (14). The 
protocol included three objective clinical signs that were discriminatory and easy to observe: 
Cough plus fast breathing (non-severe pneumonia) and chest in-drawing (severe pneumonia) 
(14). Kumar et al successfully tested the protocol in a rural community in India (15), and the 
protocol was adopted globally. 
Today, children with respiratory infections requiring antibiotic treatment at home or referral 
care are still recognised using clinical signs (rapid respiration, nasal flaring, central cyanosis 
and lower chest in-drawing) that can be learned and used by health workers with limited clinical 
training and no capacity for laboratory investigation or radiology (16). For the foreseeable 
future, WHO have stated that the presumptive case management of childhood pneumonia will 
remain an important strategy in reducing under 5 mortality. The Global Action Plan for 
Prevention and Control of Pneumonia (17) outlines some key interventions: case 
management at all levels (including community), vaccination, prevention and management 
of HIV infection, improvement of nutrition and reduction of low birth weight, and control of 
indoor air pollution. Community-level interventions have an important contribution to make 
through improving accessibility, uptake and appropriate use of services. Evidence has shown 
that correct pneumonia case management alone of infants and preschool children by 
community health workers (CHWs) resulted in a 36% reduction in pneumonia mortality (12). 
However, the necessity of targeting not only pneumonia but also other important causes of 
childhood illnesses (especially malaria and diarrhoea) in an integrated way has also been 
recognised (12, 18). Additionally, within the community it has been shown that increasing 
the number of illnesses CHWs treat increases demand for their services (19). 
Integrated community case management (iCCM) is an approach recommended by WHO, 
United Nations Children’s Fund (UNICEF) and partners where CHWs are trained to identify 
and treat symptoms of pneumonia, malaria, and diarrhoea in children under-five years, as 
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well as to detect and refer malnutrition and severely ill children to the nearest health facility 
(20). Evidence from African countries shows that CHWs, if properly trained and equipped, 
can potentially reduce child deaths from malaria, pneumonia and diarrhoea by up to 60 
percent through the delivery of iCCM (21-23).  
Children with severe pneumonia often have chest in-drawing, a symptom which some health 
care workers are not able to adequately recognise and subsequently treat or refer for necessary 
antibiotic treatment and oxygen therapy (24). Low blood oxygen saturation, or hypoxaemia, 
is a symptom of severe pneumonia that has been identified as a predictor for morbidity and 
mortality in children with respiratory illness (25). However, hypoxaemia is poorly identified 
based on clinical findings alone (26), and the inability of health care workers to promptly 
detect and refer these children, whose lives are in danger, leads to the death of many children. 
Pulse oximeters are an established technology in resource rich settings, which uses 
differential light absorbance technology to measure SpO2 and derives pulse rate (PR), and 
perfusion index (Pi) from the photo plethysmography waveform created when a light probe 
is attached to a finger or toe (27). While pulse oximetry is a reliable and non-invasive method 
for identifying children with hypoxaemia, pulse oximeters are rarely available outside of 
higher-level facilities in resource-constrained countries (28). 
1.3 THE CHALLENGE WITH PNEUMONIA DIAGNOSIS 
Pneumonia diagnosis by health workers includes counting the number of breaths for 60 
seconds in children with history of cough and/or difficulty breathing to assess whether the 
respiratory rate (RR) is higher than the normal parameters for a child of that age, as defined 
by WHO (29). In the late 1980’s, the WHO and UNICEF issued a call for the development 
of a one-minute acute respiratory infection (ARI) timer to assist health workers and CHWs 
in measuring the length of time to count the RR in children, as they felt that a timer was 
essential to count the frequency of the child’s respiratory movements to determine whether a 
child with cough has fast breathing. The specification was for one-minute timer, which 
produced an audible alarm after 30 and 60 seconds and was non-corrodible, waterproof, last 
for a minimum of 5,000 uses, was suitable for storage and use at extreme temperatures and 
high levels of humidity by health workers with different levels of training. In 1989, UNICEF 
distributed these specifications to manufacturers in different parts of the world who might be 
interested in developing such a timer, at a cost affordable to low income countries. Field tests 
of three potential devices took place in 1990 with the collaboration of the Johns Hopkins 
University in The Gambia; the Survival for Women and Children Foundation (SWACH) in 
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Chandigarh, India and the John Snow International/Intercept, Boston, in Nepal. In addition, 
assessments were made by consultants in Bolivia and Egypt (30). In all the studies, the village 
health workers and auxiliary nurses found it much easier to learn to use the timing devices to 
count the respiratory rate than to use a watch with digital display or a second hand. The 
British Standards Institute at Hemel Hempstead, Hertfordshire carried out independent 
laboratory tests according to a protocol prepared in collaboration with Ashdown Consultants, 
Hartfield, in the United Kingdom, regarding reliability in adverse climatic conditions and 
physical robustness. These tests identified problems in the functional adequacy and 
performance of the three prototype devices. The manufacturers received recommendations 
to introduce improvements in their models (30). In 1991, two new prototype timers were 
submitted for laboratory testing but neither model met the exact standard requirements. 
Detailed technical reports were returned to the manufacturers. Several months later one of 
these models, coming from China, was successfully tested (31). The designer of this model 
was assisted to increase its capacity to produce a large amount of timers. UNICEF negotiated 
the mass production and the price. A first lot of 25,000 pieces was produced at the end of 
1992 and 40,000 more were ordered for 1993 (32). Even with the deployment of the ARI 
timer counting RR continued to prove challenging to trained health workers and 
misclassification of the observed RR remained high (5, 33-36), partly due to difficulty in not 
losing count and also distracting device characteristics such as a ticking sound every second 
(37). 
1.4 DIAGNOSTIC DEVICES TO AID DETECTING SYMPTOMS OF PNEUMONIA 
In medical settings, respiratory rate counters and pulse oximeters are not referred to as 
“diagnostic” tools for pneumonia, because heightened respiratory rates and low oxygen 
saturation levels can occur in many diseases. However, an elevated respiratory rate in 
children with cough and/or difficulty breathing has been shown to be predictive of pneumonia 
and is used in the iCCM/IMCI context by frontline health workers to identify suspected 
pneumonia. If pulse oximetry is incorporated into future community level pneumonia 
guidelines, hypoxia will likely be a diagnostic indicator of severe illness and requiring 
referral to a health facility where oxygen is available. For these contextual reasons the devices 
in this thesis are referred to as pneumonia diagnostic aids. 
Since the launch of the ARI timer, different types of diagnostic aids have been developed to 
support low literate frontline health workers, consisting of both CHWs and first level health 
facility workers, to assess and classify symptoms of pneumonia. The first studies published 
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in peer reviewed journals on tools to aid counting for pneumonia diagnosis are from 1991 in 
Gadchiroli, India, where trained traditional birth attendants (TBA) who used a simple device 
- a breath counter abacus - more often classified children correctly compared to those using 
visual judgment of tachypnoea (38, 39). The researchers noted several constraints in using 
the abacus, including the inaccuracy of the built-in sandglass and the fact that TBAs reported 
difficulties focusing both on the breathing as well as on the timer. However, they still 
concluded that the device is simple, inexpensive and effective. Often, new pneumonia 
diagnostic aids have been tested in smaller, under-powered evaluations, and as each study 
uses different methodologies and measures, results are often hard to compare, as recently 
highlighted (40).  
Identification and evaluation of new diagnostic aids for improved classification of pneumonia 
ranked fifth of 20 pneumonia research priorities which were identified by a panel of global 
experts in 2014, and second most important and impactful (41). The wider use of improved 
pneumonia diagnostic aids in low-resource settings are expected to contribute to more 
accurate detection and classification of pneumonia (42) and more rational use of antibiotics 
(43). More recently, and partly in response to the scale-up of large iCCM projects in sub-
Saharan Africa and Southeast Asia, new pneumonia diagnostic aids have been developed by 
industry, academia and other partners to improve the accuracy and effectiveness of detecting 
symptoms of pneumonia in resource-poor contexts (44). Similarly, wider use of pulse 
oximeters that are appropriate for low-resource settings are expected to contribute to higher 
referral rates of children with severe pneumonia (45). This should lead to improved treatment 
and better health outcomes of children under 5 globally (46). Currently, the routine use of 
pulse oximetry in children under 5 in these settings is limited (47), despite a recent study 
demonstrating the successful implementation and use of a pulse oximeter in Malawi (48, 49). 
1.5 THE CHALLENGES IN EVALUATING NEW PNEUMONIA DIAGNOSTIC 
DEVICES 
One important step toward introduction of new RR counting devices is to understand their 
accuracy. There is no established gold standard reference (i.e. the best single test, or a 
combination of tests, that is considered the current preferred method of diagnosing a 
particular disease (50)) for evaluating RR counters (51). Reference standards that have been 
used by others include using a trained and standardised medical professional who counts RR 
with the ARI timer or use auscultation to count the RR simultaneously (5), electronic 
monitoring using capnography (52) or review of recorded videos of the child being assessed 
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(53, 54). However, all these methods have limitations. While the option of using trained 
people doing a physical assessment, either by counting chest wall movements or by 
auscultation of breath sounds with a stethoscope, is currently the most common method for 
RR measurement in general practice, studies have shown manual methods to be unreliable 
(40). Even trained health workers sometimes struggle to conduct respiratory rate counting by 
observation of abdominal and chest wall movement, and counts obtained by auscultation 
have shown to be on average 14 breaths per minute higher than those obtained by 
observations (53).  
Using videotaped children whose breathing rates have been established by expert panels to 
which exploratory devices are compared against, could be one way of increasing the 
robustness of the measurement (54-56). This methods was used as reference standard in a 
previous study by Gan et al (57) and while it was found to be a rapid and robust way to 
compare the accuracy of different manual RR counting aids, it may not be a suitable method 
for testing of more advanced tools, such as automated devices (e.g. accelerometers, acoustic 
sensors, lung ultrasound) and combined RR and pulse oximeter devices which need to be 
tested on real children. Another suggested methodology to increase the accuracy of RR count, 
established by Simoes et al (58), is to let observers count breaths for 30 plus 30 seconds, 
instead of for a full minute. Pneumograms and other electronic monitoring devices have been 
used as reference standards with varying success (58, 59) but similar to stethoscopes, they 
appear to pick up small breaths that are not appreciated when observing for chest or 
abdominal movement (53). However, new promising electronic monitoring devices have 
recently become available on the market, such as the non-invasive Masimo’s Radical-7 pulse 
oximeter device (60) connected to the Phasein ISA CO2 capnography (61) to obtain oxygen 
saturation level (% SpO2) and RR, respectively.  
Further difficulty is caused by the lack of standardisation around the use of metrics for 
evaluating the performance of pneumonia diagnostic aids. Recent evaluations have 
highlighted the difficulty in reviewing and comparing previous RR accuracy evaluations, as 
the wide variation in statistical methods of comparison hinders direct comparison of device 
performance across the different studies and methods (40). 
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1.6 COUNTRY SELECTION FOR THESE STUDIES 
Four countries were selected to conduct data collection in the different sub-studies, based on 
their pneumonia prevalence, activity community health worker programme and differing 
demographics and abilities of community health workers in each country (see Table 1). 
1.6.1 Cambodia 
Cambodia, a country in the western pacific region, has an under-five population of 1,713,221 
children with a 37.9 under-five mortality rate (62). About 47% of children die before they turn 
28 days old. Pneumonia is the leading cause of death in children between 1 and 59 months of 
age (28%), followed by other conditions (18%). Between 2005 and 2010, the country saw a 
slight increase of suspected pneumonia children taken to health facilities, however only an 
estimated of 40% of pneumonia suspected children received antibiotics (63). Mortality rates 
are also much higher in rural than urban areas, and rates vary by province. This large disparity 
among rural household reflects the poor access to effective care for rural children.  
The national policy, approved by the MOH in late 2011, provided a general framework for 
health workers introducing ORS and zinc guidelines and distribution plan. A five-year 
strategy was piloted to supplement the national policy to integrate diarrhoea and pneumonia 
at the health facility level. The updated clinical guidelines, adapted from the UNICEF/WHO 
Integrated Management of Childhood Illness (IMCI) guidelines, incorporated proven yet 
underused interventions for the prevention and clinical management of both diarrheal disease 
and childhood pneumonia (62).  
In Cambodia, village malaria workers (VMWs) were first introduced in June 2001 as part of 
an insecticide treated bed net (ITN) trial conducted by the national malaria centre of 
Cambodia (CNM) in Ratanakiri Province. Between 2004 and 2005, the VMW scheme was 
rolled-out to cover 300 villages (64). Then, in 2006 Pharmaciens Sans Frontières (PSF) in 
collaboration with CNM, the Ministry of Health’s (MoH) department for Communicable 
Disease Control-IMCI and the WHO implemented a pilot project in 52 remote villages in 
Stung Treng Province to assess the feasibility of adding case management of acute respiratory 
tract infections (ARIs) and diarrhoea in under-fives to the scope of work of VMWs. VMWs 
were trained to treat simple coughs, colds and diarrhoea as well as uncomplicated cases of 
pneumonia and to refer severe cases to the nearest health facility. Three different approaches 
were tested by randomly selecting VMWs to manage: malaria and ARIs; malaria and 
diarrhoea; or, malaria, ARIs and diarrhoea. Although a detailed comparison of feasibility and 
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efficiency within the three intervention groups was never fully assessed, findings indicated 
that it was feasible for these ‘expanded VMWs’ (eVMWs) to treat all three illnesses given 
proper training (64).  
VMWs regularly reported to the local health facility staff who supervised and supplied 
commodities for the work. Malaria has rapidly declined in all areas but pneumonia and 
diarrhoea remained major causes of U5 mortality. The MoH was willing to expand the 
coverage of these eVMWs and included diagnosis and treatment of pneumonia using the 
UNICEF ARI respiratory timers and pre-packaged antibiotics, and included ORS and zinc 
for diarrhoea (64). So far 800 eVMWs from 400 malaria at-risk villages have received a two-
day training in classifying and treating children with pneumonia, and how to refer children 
with symptoms of severe disease. These eVMWs were distributed in 10 provinces across the 
country, most predominantly in Ratanakiri (270), Stung Treng (104) and Kratie (100) 
provinces. A study conducted in 2014 in Cambodia showed that despite their utility, oxygen 
and pulse oximetry may be underused in Cambodia (65). 
1.6.2 Ethiopia 
Ethiopia, the second most populous country in Africa, has an under-five population of 
14,250,000 children with an under-five mortality rate of 64.4/100,000. The country’s 2011 
Demographic Health Survey indicated only 27% of under-five suspected pneumonia children 
were taken to a health facility/provider. An estimated 8% of pneumonia suspected children 
received antibiotics in 2011, a very slight increase from 2005 (66). Ethiopia developed the 
national implementation plan for community case management (CCM) of common 
childhood illnesses in 2010. The overall goal of this implementation plan was to ensure the 
greatest possible reduction of mortality in children less than five years of age in order to 
achieve the MDG 4 by 2015. Looking into the health service utilization and health problem 
of the country, the Ethiopian government introduced “Accelerated Expansion of Primary 
Health Care Coverage” and the Health Extension Programme (HEP). This health policy 
focused mainly on providing quality promotive, preventive and selected curative health care 
services in an accessible and equitable manner to reach all segments of the population, with 
special attention to mothers and children. The policy had a particular emphasis on 
establishing an effective and responsive health delivery system for those who live in rural 
areas. At the community level, in addition to Health Extension Workers (HEWs), there were 
also groups of Voluntary Community Health Workers (VCHW) created, and who worked in 
collaboration with HEWs to extend contact with families and the community. 
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The HEP was a defined package of basic and essential promotive, preventive and selected 
high impact curative health services targeting households. Based on the concept and 
principles of Primary Health Care (PHC), it was designed to improve the health status of 
families, with their full participation, using local technologies and the community's skill and 
wisdom. HEP was similar to PHC in concept and principle, except HEP focused on the 
community level and was implemented by HEWs. The Federal Ministry of Health and 
regional health bureaus were involved in formulating policy and guidelines for the HEP as 
well as provision of financial and technical support. HEWs must be women aged at least 18 
years with at least a 10th grade education. HEWs were selected from the communities in 
which they reside in order to ensure acceptance by community members. Following selection, 
the HEW completed a one-year course of training which includes coursework as well as field 
work to gain practical experience. Components of the HEP included disease prevention and 
control, family health, hygiene and environmental sanitation, health education and 
communication (67). More recently, with the support of UNICEF, HEWs were trained on 
iCCM and equipped to properly assess, classify and manage pneumonia, malaria, diarrhoea 
and severe acute malnutrition. As of May 2017, 37,000 HEWs had been trained in iCCM. 
HEWs did not use any special devices to diagnose pneumonia. Instead, the government had 
provided watches to HEWs that clearly display seconds for counting of breathing rate. HEWs 
are able to treat fast breathing with amoxicillin (68). 
Currently, in all the rural kebeles of most regions including the Southern Nations, 
Nationalities and People’s Regional State (SNNPRS), more than 85% are at full scale of 
implementation of the HEP. Nationally, more than 3,500 health workers and districts HEW 
focal persons have been trained and engaged in supervisory activities. According to the 2016 
Ethiopia Health Indicator Report, the total number of HEWs who were active in SNNPR was 
12,353 (69).  
In 2019, a retrospective cross-sectional study conducted in 14 hospitals in Ethiopia showed 
low utilization of pulse oximetry (10%) in hospitalized children under five with pneumonia 
(70). The finding likely reflects the low availability of pulse oximeters and low awareness of 
healthcare workers to routinely use pulse oximeters during triaging and diagnosing of 
patients. In Ethiopia, patients under five with a primary diagnosis of pneumonia are rarely 
screened for hypoxemia with a pulse oximeter, and hypoxemia may be severely under 
diagnosed (70).  In addition to functioning pulse oximeters, children with hypoxaemia need 
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to be referred to hospitals for oxygen therapy; however, access to oxygen is inconsistent 
across most referral facilities in Ethiopia (71). 
1.6.3 South Sudan 
South Sudan, one of the world’s newest countries, has an under-five population of 1,785,000 
children with neo-natal deaths at 43% (72). A larger proportion of children die in the 1-59 
months’ age bracket (60%) and a slightly higher proportion of those children between 1-4 years 
of life. 28% of post neonatal children are affected with pneumonia and 18% die of other 
conditions. The 2018 South Sudan Countdown Report showed 48% of under-five suspected 
pneumonia children were taken to a health facility/provider and only 33% received antibiotics 
(72). In order to combat the high child mortality rates iCCM has been implemented in South 
Sudan since 2005. By 2019, the iCCM programme was implemented in 60 of the 79 counties 
with support from international NGOs. iCCM in South Sudan is built into the Community-
Based Child Survival programme, which is part of the MOH’s 2009 Community Child 
Survival implementation guidelines “Community Based Management of Malaria, 
Pneumonia & Diarrhoea”. This guideline clearly indicated the elements of the community 
health package for malaria, diarrhoea and pneumonia, the treatment regimen and content of 
training for community drug distributors (CDDs). The majority of CDDs were illiterate and 
female, were considered volunteers as they only receive in-kind incentives for participating 
in the programme, were nominated by their communities, and served between 20 to 40 
households. Each CDD maintained a box of supplies which includes a month’s supply of 
drugs, assessment and diagnostic tools (ARI timer and counting beads), job-aids, patient 
registers, and basic supplies such as scissors and pens (73). CDD supervisors were paid staff 
recruited from the catchment areas they are assigned to supervise and oversee 15 to 20 CDDs, 
and move throughout the county primarily on foot, also restocking the CDDS with drugs and 
supplies (73). In March 2017, the Republic of South Sudan launched the Boma Health 
Initiative (BHI), a nationwide strategy to improve access to essential health services. It was 
designed to standardise the package of community health services, strengthen linkages 
between communities and primary health facilities, and improve community ownership and 
governance of health services.  
There is little data on the availability of pulse oximetry and oxygen supplies in South Sudan, 
but in our work in country for this thesis we did not see functioning devices in any of the 
health facilities we attended. 
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1.6.4 Uganda 
Uganda is an East African country with a population of approximately 37.85 million based 
on the 2014 census (74). Uganda has an under-five population of 7,115,000 children with an 
under-five mortality rate of 66 deaths per 1,000 live births (75). Pneumonia, again, is the 
leading cause of these deaths (21%) with malaria being the second leading cause (19%), while 
31% of neonatal deaths are caused by premature births. The most recent health survey data 
indicated 79% of under-five suspected pneumonia children were taken to a health facility and 
47% received antibiotics. A clear increase occurred in health seeking practices amongst 
children with suspected pneumonia from 2000 to 2011 (75).  
The Ugandan health system is composed of public, private and not for profit providers as well 
as traditional medicine providers, with overall 5,229 health facilities (76). In Uganda MoH has 
implemented the Village Health Team (VHT) concept since 2006, and in 2010 the iCCM 
strategy was added to the VHT responsibilities (77). In the VHT concept, every village in 
Uganda (which is the lowest administrative unit) is supposed to have five community health 
volunteers. These five volunteers are selected by the village itself, following pre-set criteria, 
are trained in a five day basic package following which they are supposed to mobilize their 
community members for health action across a wide of health prevention and promotion 
interventions including malaria prevention, water and sanitation and family health. Two of 
the five VHT members are further selected against other criteria and trained in a six day 
iCCM package, and subsequently equipped with a box with selected primary medicines 
(Color coded Coartem, rectal artesunate, colour-coded Amoxicillin, zinc and ORS) and a 
register to manage children with signs of uncomplicated malaria, pneumonia and diarrhoea 
and refer children with signs of severe illness. VHT do follow up visits on the third day to 
ensure that children are improving and complying with the prescription. For new-borns, the 
VHTs do home visits on day one, three and seven to identify danger signs and refer as 
indicated. The standard UNICEF ARI timer is used to guide counting of respiratory rate in 
children with cough. By 2015 Uganda had deployed more than 30,000 VHTs in approximate 
one-third of the country (about 30 districts) (78).  
Availability of pulse oximetry and access to oxygen is low in Uganda, with a  survey of hospital 
facilities in Uganda has previously shown that 65–76% of operating theatres in Uganda do not 
have pulse oximeters (79).
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Table 1 Country profiles for each research sites in relation to pneumonia diagnosis and treatment statistics at community level 
 Cambodia Ethiopia South Sudan Uganda 
Pneumonia deaths (% of total under 5 deaths [17])  17% 17% 21% 16% 
Pneumonia incidence in under 5s (number of episodes/child/year) [18] 0.25 0.28 0.32* 0.27 
Proportion of children <5 with suspected pneumonia received antibiotics [19] 39% 7%  33% 47% 
Name for CHWs Extended village 
malaria worker 
(eVMW) 
Health extension 
worker (HEW) 
Community drug 
distributor (CDD) 
Village health team 
member (VHT) 
Length of initial training 5 days (2 days malaria 
training + 3 days sick 
child case 
management) 
1 year 6 days 11 days (5 days basic 
training + 6 days sick 
child case 
management) 
Literacy level Low High Extremely low Low-median 
Current pneumonia diagnosis tool ARI timer Wrist watch /ARI 
timer 
ARI timer + beads ARI timer 
Catchment population per CHW 130-150 households 400-500 households 250-300 households 250-500 households 
Average case load per month 8 12 9 12 
* Data is for Sudan
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2 RATIONALE FOR THESE STUDIES 
This thesis originated with the idea that while there had been work done to show that the iCCM 
intervention was effective and feasible in low resource settings (35, 80), and specifically 
evaluations done on the pneumonia elements of the iCCM algorithm (81), no large scale studies 
focused on pneumonia diagnostics aids have been conducted in these settings and populations.   
Additionally, while the issues with the current standard practice diagnostic aid, the ARI timer, 
are well documented in the literature (40, 82, 83), there is a need to broaden the focus, and 
investigate the usability of other types and classes of potential diagnostic aids, notably pulse 
oximeters. While there have been some recent studies done on the use of pulse oximeters in 
these settings (84-87), none have comprehensively looked at the performance and utility of 
pulse oximetry in these settings.  
From a health systems perspective it is not clear from the current literature where best new 
diagnostic aids should be situated or implemented for maximum effectiveness. While some 
work has been done, for example, on the cost effectiveness of introducing pulse oximetry at 
scale (45), no data existing on its relative utility or performance at the different levels of health 
systems in these settings.  
From a methodological perspective, as potential new technologies are introduced it is important 
to have a robust and established method to evaluate their performance, in a consistent and 
generalizable way. There is an ongoing discussion in the literature on the need for this (40, 51). 
This thesis should add to this discussion and provide learnings on how best to develop a 
reference standard and conduct these types of evaluations in the future. 
Effective interventions have often failed due to poor acceptability and a lack of awareness of 
stakeholder opinions (88). In documenting the factors that CHWs and national stakeholders 
feel influence the introduction of these types of technology at scale we hope to better support 
their future introduction. 
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3 CONCEPTUAL FRAMEWORK 
Multiple frameworks exist for the introduction of new technologies or innovations. For this 
thesis we developed a framework (see Fig. 2) adapted from the WHO Health technology 
assessment of medical devices (89) and Mytton et al’s introducing new technology safely (90). 
The WHO first developed a model to reflect the types of research questions that must be 
answered for the coherent introduction of technologies, especially medical devices, into health 
systems. These start with the need for the technology to be safe for its intended use, followed 
by being accurate and finally acceptable and usable to its intended users. Further to this, our 
framework reflects the special considerations that need to be addressed when introducing new 
technology in low-resource settings.  
Stage 1: The first stage in the introduction of a new technology is typically where formative 
research is used to understand the current situation and evaluate possible technologies for 
further testing. Sub-study I used a human centred design (HSD) approach that engaged end-
users and national stakeholders in helping us to understand their perceptions of the important 
attributes in potential pneumonia diagnostic aids (91). Also in this stage we conducted 
formative research with CHWs and national stakeholders to support the device selection 
process, where we used a ranking and scoring process to select the nine devices for field testing 
from a possible 188 devices (92). The safety of the new technologies also needs to be tested at 
this stage. In this regard we conducted laboratory testing of the technologies that had not be 
tested in these environments before, i.e. the pulse oximeters. 
Stage 2: Once suitable potential technologies have been selected for further testing, the next 
stage is then to look at their performance in these settings. In sub-study IIa and IIb we looked 
at performance of the devices in measuring RR and SpO2 in comparison to reference standards. 
Stage 3:   Subsequently, the suitability for the setting was investigated when in sub-study III 
the nice devices were tested for utility, usability and acceptability in routine practice over three 
months.  In looking at acceptability we used the theoretical framework of acceptability 
developed by Sekhon et al (93), which defined acceptability as “ a  multi-faceted construct that 
reflects the extent to which people delivering or receiving a healthcare intervention consider it 
to be appropriate, based on anticipated or experiential cognitive and emotional responses to the 
intervention”. The authors further define seven component constructs of acceptability as: 
affective attitude, burden, ethicality, intervention coherence, opportunity costs, perceived 
effectiveness and self-efficacy.
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Figure 2 Stages of introducing a new technology - adapted from ‘Health technology assessment of medical 
devices’ [15] and ‘Introducing new technology safely’ [16]. 
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4 AIMS AND OBJECTIVES 
General aim 
To identify and evaluate the most accurate, acceptable and user-friendly respiratory rate 
timers and pulse oximeters for diagnosis of pneumonia symptoms in children by frontline 
health workers in low-resource settings. 
 
Specific objectives 
Objective 1: To explore the perspectives of CHWs and national stakeholders regarding the 
potential usability and scalability of potential pneumonia diagnostic aids to aid community 
assessment of pneumonia signs (Sub-study I – Paper 1). 
Objective 2: To measure the performance of four RR counters to diagnose fast breathing as a 
sign of pneumonia when used by frontline health workers in Sub-Saharan Africa and 
Southeast Asia. (Sub-study IIa – Paper 2) 
Objective 3: To measure the performance of five pulse oximeter devices to measure oxygen 
saturation as a sign of severe pneumonia, when used by frontline health workers in Sub-
Saharan Africa and Southeast Asia. (Sub-study IIb – Paper 3) 
Objective 4: To explore the usability and acceptability of RR counters and pulse oximeter 
devices as perceived by caregivers and frontline health workers in Sub-Saharan Africa and 
Southeast Asia. (Sub-study III – Paper 4) 
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5 METHODS 
5.1 STUDY AREA AND POPULATION 
This was a series of multi-country studies implemented in Cambodia, Ethiopia, South Sudan 
and Uganda. All four countries have a high proportion of under-five deaths caused by 
pneumonia (16-20%) and all are implementing ministry of health defined iCCM and IMCI 
programmes. However, characteristics of the health worker programmes differed by country, 
such as length of training, literacy level and current pneumonia diagnostic devices used (see 
table 1).  
For sub-study I, formative research, focus group discussions were held in each of the countries. 
The study sites selected for conducting sub-study IIa & IIb were all district hospitals selected 
after analysis was conducted on patient flow to understand if the individual research sites could 
support the sample size required by the study for enrolment (see Table 2). For sub-study III a 
sample of frontline health workers who took part in the previous sub-studies were selected, and 
all lived within 20 kilometres of the hospitals used in sub-study IIa & IIb. 
Table 2 Demographic characteristics of the study sites in Cambodia, Ethiopia, South Sudan and Uganda 
Description Cambodia 
Ratanakiri province 
Ethiopia 
Dale & Shebedino 
Districts SNNPR 
South Sudan 
Aweil district 
Northern Bahr el 
Ghazal State 
Uganda  
Mpigi 
district 
Population  184,000 529,041 128,295 250,548 
Under 5 
population n (%) 
37,720 (21) 82,582 (16) 25,000 (19) 51,363 
(21) 
No of CHWs 270 161 1683 650 
No of health 
centres 
23 19 20 39 
No of hospitals 2 2 1 1 
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The specific study sites (see Fig. 3) were Mpigi Health centre IV, approximately 45 miles from 
Kampala in Uganda; Yergalem District Hospital in Southern Nations and Nationalities and 
People’s Region (SNNPR) in Ethiopia; Borkeo Hospital in Ratanakiri province in Cambodia; 
and Aweil General Hospital in Northern Bahr el Ghazal state in South Sudan. For sub-study 
III, frontline health workers were selected based on having participated in sub-study 2 or 3, and 
were within 20 kilometres from the same health facility used in that sub-study, in order to have 
access to functioning oxygen equipment and case management of severe illness capabilities.  
In Cambodia, the study site was in Rathanakiri province, which is approximately 540 
kilometres from the capital Phnom Penh. In Rathanakiri there are 270 CHWs trained in iCCM 
and each has had 6 days training. They have a low level of literacy and numeracy and 
typically treat patients in their home. 
In Ethiopia, the study site selected was in Dale and Shebedino districts in SNNPR, which are 
districts of approximately 529,000 people and is approximately 330 kilometres south of the 
capital Addis Ababa. Yergalem is the capital city of Dale district and the site of the referral 
hospital we conducted Sub-study IIa and IIb at. There are 19 health centres and 191 HEWs 
in Yergalem and Sub-study I and III were conducted amongst representative samples of these 
HEWs. 
In South Sudan, the study site selected was in Aweil Centre and West counties in Northern 
Barh El Ghazal state. This state is in the north of the country, 880 kilometres from the capital 
Juba. There were 1,683 CDDs trained in the Home Management of Malaria programme, with 
955 trained for six days on the full iCCM package. In Aweil the majority of CDDs had 
extremely low literacy and numeracy, hence within the programme two devices for 
facilitating the counting of respiratory rate in children with cough were used, the ARI timer 
and counting beads. The beads were color-coded and in different sizes to distinguish the three 
age groups. 
In Uganda the studies were situated in Mpigi District, located in Central Uganda along the 
Kampala-Masaka highway, approximately 40 kilometres from Kampala. The district was 
largely rural but had implemented the VHT strategy longer than all the other districts. The 
district had a total population of approximately 210,000 with 40,000 children U5. It consisted 
of 2 counties (Mawokota North and Mawokota South), 9 sub-counties and 332 villages. Mpigi 
has one referral hospital (HC4), 18 sub-county health centres (HC3), 412 first level health 
facilities (HC2) and 650 VHTs (HC1) who are all trained in iCCM and actively supported by 
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Malaria Consortium. Between February 2011 and March 2013 VHTs in Mpigi had detected 
and treated more than 48,000 cases with fast breathing. VHTs used the ARI timer to support 
them to count RR in Mpigi. 
 
 
Figure 3 Maps of the study areas highlighting 1) Uganda and Mpigi district, 2) Ethiopia and the 
Southern Nations and Nationalities and People’s Region (SNNPR), 3) South Sudan and the Northern 
Barh El Ghazal state and 4) Ratanakiri province in Cambodia 
 
 
 
Map 2 Ethiopia 
Map 3 South Sudan Map 4 Cambodia 
Map 1 Uganda 
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5.2 SUMMARY OF RESEARCH METHODS 
The different sub-studies in this thesis use a variety of methods as detailed below (see Table 
4). 
Qualitative research methods 
Sub-study I and III used qualitative methods to comprehensively explore participant attitudes 
and perspectives towards various diagnostic devices. Specifically, in sub-study I, a series of 
pile sorting exercises and focus group discussions were held in each of the four countries with 
community health workers and national stakeholders to explore their perspectives on the 
potential usability and scalability of the proposed diagnostic aids. In Sub-study III semi-
structured exit interviews were used to gain the user perspectives on the acceptability of the 
nine diagnostic aids they had bene using in routine practice. 
Pile sorting exercise 
Pile sorting is a qualitative method used mainly in social science and health research. It aims 
to capture participants’ opinions or experiences by having them sort cards of words or pictures 
or items themselves into piles that classify a range of their opinions or categories of interest 
(94). Conducting a focus group discussion immediately following a pile sorting activity is 
designed to capture and explore participants’ decision-making rationale for their choice and 
improve the quality and depth of data captured.  
Focus Group Discussions 
Focus group discussions (FGDs) are widely used in social science and applied research, as a 
data collection method, to establish opinion trends in selected populations. A FGD consists of 
seven to ten people, selected based on their common characteristics, relevant to the research 
question being investigated (95). 
Semi-structured exit interviews 
Semi-structured, conversational interviews are often used in qualitative research. They may be 
in-depth or key informant interviews. These are often selected if the topics being discussed are 
more sensitive or there are concerns that group dynamics may repress or hinder open and frank 
discussion and limit the quality and scope of the data being collected (95). 
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Quantitative research methods 
Sub-studies II and III used quantitative methods to document the performance and usability of 
both the four RR counters and the five pulse oximeters in hospital and community settings.  
Cross sectional surveys 
Cross-sectional surveys are descriptive study designs in which a sample of a reference 
population, in this case children under five years of age, are examined at a given time point or 
over a short period of time. These types of studies can provide a snap-shot of the study outcome, 
together with any associated characteristics. These types of studies are used to estimate the 
prevalence of an outcome and generate hypotheses for future research studies. However, due 
to the potential for timing bias, they cannot be used to make causal inferences (96).  
Direct observation 
Participant observation is often used as a complimentary tool with interviewing. It involves 
systematically watching and recording behaviour and other characteristics of the user using 
checklists or other data collection tools. Observation may be passive or active depending on 
the degree of involvement (95). This can mean participants may change their behaviour as they 
know they are being watched, this is called the Hawthorne effect (97). 
Medical record review 
Record reviews use pre-recorded patient data to answer a research question. The records must 
be able to produce data that are both valid and reproducible. Record reviews are limited by the 
scope of available and accessible routine data. Ethical considerations in relation to patient 
confidentiality can sometimes arise, as can data qualitative and validity issues (98). 
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Table 3 Overview of sub-studies and associated research design, sample size and methods 
Sub-study Design and sample Setting Analysis and outcome 
I: Childhood pneumonia diagnostics: Community 
health workers and national stakeholders’ differing 
perspectives of new and existing aids 
Qualitative pile sorting exercise and focus group 
discussions with health workers and national 
stakeholders (n=16 groups) 
Four FGDs were held in Cambodia, 
Ethiopia, South Sudan and Uganda. 
Aggregated pile-sorting data and thematic content analysis was 
used to identify thematic patterns between countries and groups 
on their perceptions and needs in relation to diagnostic devices. 
IIa: Performance of four respiratory rate counters to 
support community health workers to detect the 
symptoms of pneumonia in children in low resource 
settings: A prospective, multi-centre, hospital-based, 
single-blinded, comparative trial 
Quantitative, observational, hospital-based, 
cross sectional study 
n=454 children under 5 years old & 79 
community health workers 
District hospitals in:  
1) Ratankiri, Cambodia 
2) Yergalam, Ethiopia 
3) Aweil, South Sudan 
4) Mpigi, Uganda 
Agreement between test devices and reference standard as 
shown by: 
x Mean difference  
x Proportion agreement 
x Bland Altman plots 
RR classification agreement shown by:  
x Kappa statistic and  
x Positive and negative percent agreement. 
IIb: Performance of five pulse oximeters to detect the 
symptoms of severe illness in children under five by 
frontline health workers in low resource settings – 
results from a prospective, multicentre, single-
blinded, trial in Cambodia, Ethiopia, South Sudan and 
Uganda 
Quantitative, observational, hospital-based, 
cross sectional study 
 n=454 children under 5 years old) 
District hospitals in:  
1) Ratankiri, Cambodia 
2) Yergalam, Ethiopia 
3) Aweil, South Sudan 
4) Mpigi, Uganda 
Agreement between test devices and reference standard as 
shown by mean difference in % SpO2 and classification 
agreement of hypoxaemia shown by Kappa statistic and positive 
and negative percent agreement. 
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III: Acceptability, usability and utilisation of 
pneumonia diagnostic aids, as perceived by 
caregivers and frontline health workers, in supporting 
the detection of pneumonia symptoms in Sub-
Saharan Africa and Southeast Asia 
Mixed methods, observational, community-
based, cross sectional study 
Direct observation and patient record review 
n=1291 children under 5 years old and 100 
frontline health workers 
Exit interviews n=40 frontline health workers 
Community and health facility 
settings in:  
1) Ratankiri, Cambodia 
2) Yergalam, Ethiopia 
3) Aweil, South Sudan 
4) Mpigi, Uganda 
Usability measured through procedures adherence scores 
Thematic content analysis was used to identify thematic patterns 
between groups on their perceptions of the acceptability of the 
devices 
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5.3 STUDY DESIGNS 
5.3.1 Sub-study I 
Sub-study I used a qualitative study design with an explanatory approach used a combination 
of pile sorting activities and focus group discussions (FGDs) to explore the factors that 
influences the usability and scalability of various types of pneumonia diagnostics devices to 
frontline health workers and national stakeholders in the four countries. The sample size of 
qualitative studies is not predetermined but data are collected from participants until no new 
further information is being captured (99). 
The study protocol and data collection tools were developed by the doctoral student in 
consultation with the principal investigator and the four country research teams at a protocol 
design workshop held in Kampala, Uganda in autumn 2014. Purposive sampling was used to 
select participants in each of the four countries for the eight FGDs held with a total of 31 
representatives of national and regional ministries, relevant staff from multilateral 
organizations and NGOs working at regional and national levels. A further nine FGDs, three 
per country as Uganda was unable to participate due to time constraints, were held with 63 
CHWs who were selected from lists of active CHWs with active experience of pneumonia case 
management in each country. The numbers of FGDs were chosen to achieve maximum 
thematic saturation amongst both groups of participants, balanced with available time and 
resources. Before data collection was conducted the discussion guides were translated into the 
local languages, pre-tested and modified as required. Data collection happened between 
December 2014 and January 2015 in local language. Seven device types were demonstrated to 
participants, who were also provided a written explanation of each device functionality and 
purchase cost. The devices were:  
1. The ARI timer (and additional counting beads in South Sudan);  
2. A fingertip pulse oximeter;  
3. A hand held pulse oximeter;  
4. A smartphone application which tracks the breaths counted when the screen is tapped on;  
5. A simple feature phone application which tracks the breaths counted when a button is 
pressed;  
6. A pulse oximeter probe attaching to a smartphone;  
7. A joint device combining the RR counting application and a pulse oximeter probe using 
the same smartphone (only shown to some groups in Ethiopia, South Sudan and Uganda) 
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Individual participants placed cards with various device names into different piles according to 
their perceived usability, and again for their perceived scalability. The piles were 
predetermined by the researchers (Table 4). The facilitator recorded the overall pile sorting 
results (i.e. how many times a device was placed in each pile) into a pro forma results table. 
Participants were asked throughout the FGDs to explain their choices and give a rationale for 
their placement of the various devices in the different piles. Each session was digitally recorded 
with the informed consent of all participants.  
Table 4 Definitions of pile sorting categories 
Usability  
Pile 1 Able to use the device in the community setting 
Pile 2 Able to use the device with reservations in the community setting 
Pile 3 Possibly unable to use the device in the community setting 
Pile 4 Unable to use the device in the community setting 
Scalability  
Pile 1 Feasible to scale up 
Pile 2 Feasible with reservations to scale up 
Pile 3 Possibly unfeasible to scale up 
Pile 4 Unfeasible to scale up 
 
5.3.2 Sub-study II 
Sub-study II, was the performance evaluation element of this thesis, and was a multi-centred, 
single-blinded, comparison of the performance of RR counters and pulse oximeters to detect 
the signs and severity of pneumonia in the hands of frontline health workers using two 
reference standards, a continuous monitor and an expert clinician. 
The sample size calculation was based on the primary outcome, i.e. the precision of the mean 
difference between the device and the reference respiratory count, assuming normal 
distribution. A standard deviation of SD=7 for the difference was obtained in a previous study 
evaluating the performance of respiratory rate counters [24] and in requiring a maximal total 
length of the 95% confidence interval of 4 units, which the same range as the WHO accepted 
maximal absolute breathing rate deviance (e.g. ±2 breaths/min), the minimum sample size was 
47 children per strata for independent observations. The two age strata in the study were i) 0 to 
60 days and ii) 2 to 59 months, and three devices pairs per country gave a total sample size of 
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282 children. The sample size was then increased by fifty percent to n=423 and rounded off to 
430 children per country to accommodate for potential clustering at health worker level (100). 
 
Figure 4 Data collection for sub-study II in Mpigi Health Centre IV, Uganda 
In each country a research team consisting of a research nurse, a research officer, three research 
assistants and an expert clinician conducted the various enrolment procedures and assessments. 
All of the CHWs/FLHFWs underwent two days of training on a set of devices, refresher 
training on how to examine a child/young infant, and used a set of two or three investigational 
devices each time, to obtain measurements for RR. On consenting to the studying and entering 
the research room the child was positioned comfortably on the mother’s lap and continuous 
monitor reference attached on the child. Once the child was calmed an assessment was then 
performed by the CHWs/FLHFW. Two measurements of RR/SpO2 were recorded on a data 
form, along with the corresponding continuous monitor reference measurements. The expert 
clinicians then entered the research room and took two measurements using a stopwatch for 
RR or the same pulse oximeter for SpO2. In the RR cases, the maximum time lag between the 
measurement of the expert clinician and the CHW/FLHFW was set to not exceed 5 minutes. 
As an additional comparison, simultaneous Masimo capnography RR measurements were 
recorded also for the expert clinician. The CHW/FLHFW was asked to classify the child into 
fast or normal breathing using WHO age-specific cut-offs for RR and hypoxemic or not-
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hypoxemia using the pulse oximeters, and their classification was recorded along with the time 
points for all measurements. During the evaluation, research assistants equipped with a 
structured checklist observed the CHWs/FLHFWs using the different devices and documented 
their skills and challenges experienced during the evaluation. In each country data was double 
entered in EpiData (www.epidata.dk). The cleaned country data sets were then merged and re-
structured by the study statistician into a full study data set. The study protocol has been 
published (101) and the study is registered with the Australia New Zealand Trials Registry 
(ANZCTR) (Ref: ACTRN12615000348550). A video documenting the study methods can be 
seen here.1 
5.3.3 Sub-study III 
Sub-study III was focused on the usability and acceptability evaluation element of this thesis. 
It was a mixed methods, multi-centred, observational study using both qualitative and 
quantitative data to document the usability and acceptability of devices to detect symptoms of 
pneumonia in the hands of CHWs and FLHFWs in routine practice. The study incorporating 
structured observations and checklists, and qualitative exit interviews with a sample of health 
workers in the four countries. A purposive sample of 100 HWs (5:1 ratio of CHWs to FLHFWs 
as in the previous performance evaluation element of the trial) were selected from the four 
countries and represented 33.3% of all health workers recruited for the previous performance 
evaluation phase of the study. This sampling was representative of gender, age and experience 
levels while ensuring frontline health workers selected were in close proximity to health centres 
for oxygen support for severe or referral cases. Health workers were trained for two days to use 
a RR counter and a pulse oximeter as part of their routine iCCM/IMCI activities. Each health 
worker had to pass a competency-based assessment before participating in the evaluation. 
                                                 
1 Here is a link to the protocol video: https://tinyurl.com/y2gt69qy  
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Figure 5 Sub-study III data collection in Ratanakiri, Cambodia 
The study team of two research assistants scheduled visits with each health worker three times 
(once a month) during the evaluation, each time targeting five assessments of each 
CHW/FLHFW. All children aged between 0-60 days who presented to CHWs/FLHFWs were 
included in the study regardless of their symptom status. Children between 2-59 months were 
only included if they presented with cough or difficulty breathing. Children who had caregivers 
younger than 18 years were excluded. The health worker took the medical history of the child 
as per iCCM/IMCI guidelines, and if cough and/or difficulty breathing was present the health 
worker used the RR device to count the number of breaths in one minute; a procedure that was 
repeated twice with the highest reading used for RR classification. The observed RR was used 
by the health worker to decide whether or not to provide treatment for fast breathing pneumonia 
using the national treatment guidelines. If fast breathing was detected the health worker 
assessed for hypoxemia using the pulse oximeter by taking two SpO2 readings, using the lowest 
reading for classification of hypoxemia. All children with signs and symptoms of severe 
pneumonia and with SpO2 <90% were referred. Paper-based data collection tools were 
developed to collect data on screening, usability and adverse events. Structured perception 
checklists were developed for health workers and caregivers. Semi-structured interview guides 
were developed for the exit interviews with health workers. All completed forms were returned 
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to the Malaria Consortium office for double data entry using EpiData version 3.1 (EpiData 
Association, Odense, Denmark) and filed. The qualitative data collection consisted of in-depth 
interviews with health workers at the end of data collection to capture their views on usability 
and acceptability. Each data form had a Unique Identification Code (UIC) in order to link data 
from different forms in the database.  
5.4 DATA ANALYSIS 
In this section, the data analysis methods applied to the different sub-studies in this thesis are 
described in terms of their overall principles, strengths and weaknesses. Some of the specific 
limitations relating to the analysis performed in the different sub-studies are further discussed 
in section 6.2. 
5.4.1 Pile sorting 
In Sub-study I pile sorting was used to capture participants’ opinions or experiences by having 
them sort devices into piles that classify a range of opinions or categories of interest around 
usability and scalability (94). Results from the pile sorting exercises were collated in Microsoft 
Excel (2011). Comparative analysis was done to show the differences in views by respondent 
group and country. 
5.4.2 Direct content analysis 
In sub-studies I and III the audio recording from all FGDs and semi-structured exit interviews 
were transcribed intro English by the research teams in each country. All transcripts were 
imported into the qualitative software, NVivo (Version 10 QSR International Pty Ltd; USA 
2015) for sorting and coding. Inductive and deductive approaches were used to assign codes to 
the relevant text. These codes and sub-categories were then categorised and a thematic content 
analysis was performed (99). The differences and similarities in thematic content between 
countries and between CHWs and national stakeholders was explored through the use of 
Comparative interpretation (102).  
5.4.3 Descriptive statistics 
In sub-studies II and III descriptive analysis to identify basic frequencies were carried out and 
were reported for each country. Characteristics were described first for health workers and then 
for children.  
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5.4.4 Procedure Adherence Score 
In sub-study III device usability was reflected by a procedures adherence score, developed for 
both RR counters and pulse oximeters using device user checklist data. This checklist included 
tasks such as ensuring if the child was calm, if the health worker used their device correctly 
along with other recommended tasks to successfully diagnose a child with pneumonia. Six 
questions were summed to create the RR procedure adherence score (with a maximum score 
of 6. Eleven questions were summed to create the pulse oximeter procedure adherence score 
for the handheld and mobile devices. Similar points and coding was followed as above. For 
these devices, there were 3 questions related to selecting and attaching correct cables to devices. 
Therefore, the maximum score for the fingertip pulse oximeters was 8, as these devices do not 
have multiple probes. Mean procedure adherence scores and standard deviations are presented.  
Three models, one each for RR counters, fingertip pulse oximeters and handheld pulse 
oximeters, were developed to identify if a basic relationship existed between procedure 
adherence and device types. Crude association assessed by linear regression for each model, 
with each device compared to the same base device; MK2 ARI timer for RR and Contec for 
fingertip pulse oximeters and Lifebox for handheld pulse oximeters. The MK2 ARI timer was 
used for RR comparisons because it is the closest representation to current standard practice. 
Similarly, Lifebox was seen as the closest device to standard practice. P-values along with the 
95% confident intervals (CI) were presented.  
5.4.5 Bland Altman Plots 
In sub-study IIa, to visualise the agreement between a test device and a reference standard 
Bland-Altman plots were produced (103). Data can be analysed both as unit differences plot 
and as percentage differences plot (104). The analysis of Bland Altman plots provides a simple 
way to evaluate any bias existing between the mean differences, and also to estimate an 
agreement interval, within which fall 95% of the differences of the test device, compared to the 
reference (105). The plots define these intervals of agreements, but they do not say whether 
those limits are acceptable or not (106). Therefore acceptable limits should be defined a priori, 
based on clinical necessity, biological considerations or other study aims and objectives (106). 
5.4.6 Agreement statistics 
In previous performance evaluations of pneumonia diagnostics different measurement 
statistics have been proposed to best reflect the performance of the different devices in 
comparison to the reference standard used (54, 107). In sub-study II(a&b) we followed the 
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recommendations of the US Food and Drug Administration (108), which state that when 
evaluating a new diagnostic aid in comparison to a non-reference standard, unbiased 
estimates of sensitivity and specificity cannot directly be calculated. Therefore, they 
recommend that the terms sensitivity and specificity are not appropriate in describing the 
comparative results. They further suggest that the same numerical calculations are made, but 
the estimates are called positive percent agreement (PPA) and negative percent agreement 
(NPA), rather than sensitivity and specificity. They suggest this better reflects that the 
estimates are not of accuracy but of agreement of the new test with the non-reference 
standard. In addition the recommend that quantities such as positive predictive value, 
negative predictive value, and the positive and negative likelihood ratios cannot be computed 
since the subjects’ condition (as determined by a validated reference standard) is unknown.  
5.4.7 Cohen’s Kappa statistic (N) 
Cohen’s Kappa statistic (N) was developed and most often used to measure interrater 
agreement, while also accounting for chance (109), and because of this we included this statistic 
in our analysis in sub-study II (a&b). In interpreting Kappa (N) values Altman recommends 
intervals of agreement as follows: <0.20 as poor, 0.21-0.40 as fair, 0.41-0.60 as moderate, 0.61-
0.80 as good, and 0.81-1 very good (105).  
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5.5 ETHICAL CONSIDERATIONS 
Studies in this thesis originated from a grant funded by Bill & Melinda Gates Foundation 
entitled “Use of improved tools for measuring respiratory rate and oxygen saturation among 
community health workers: Sub-Saharan Africa and South-East Asia”. The project was 
implemented by Malaria Consortium, with Dr Karin Källander as principal investigator. 
The studies was approved by ethical review boards in each study country at national or regional 
level - in Ethiopia from the Southern Nations Nationalities Peoples' Region Health Bureau 
Health Research Review Committee (Ref: 6-19/10342); in Uganda, from the Uganda National 
Council for Science and Technology (UNCST) (ref. HS 1585); in South Sudan from the 
Research and Ethics Committee at the Government of South Sudan, Ministry of Health (Dated 
23/05/2014); and in Cambodia from the National Ethics Committee for Health Research (Ref: 
0146 NECHR), Ministry of Health, and by the Regional Ethics Committee in Stockholm, 
Sweden (Ref. 2017/4:10). 
Written informed consent was obtained from all research participants who provided primary 
data in all elements of data collection, both quantitative and qualitative. National, regional and 
local stakeholders in each of the four countries were engaged and updated on all aspects of the 
study before data collection commenced. 
While all protocols and study sites had made provision for adverse events, as all test devices 
were non-invasive, this was deemed a very low-risk trial. On the recommendation of the 
scientific advisory committee, trials insurance was put in place for the duration of data 
collection in each of the four research sites. No adverse events were reported during or after 
data collection. 
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5.6 DEVICE SELECTION 
To select the test devices several activities were conducted prior to the field trials. In the initial 
landscape review 188 possible diagnostic aids were identified (110). These devices were 
further evaluated by a technical expert to review their technical specifications in relation to the 
specific research settings (111). Thirdly, all potential devices were scored and ranked using 20 
device attributes, including measures of usability, utility, scalability and user acceptance. Full 
details of the attributes can be found in Appendix 1. In contrast to the respiratory rate counters 
identified, the eight selected pulse oximeters had not previously been field tested in these 
settings, and therefore, before conducting the field trials they were first tested in a laboratory 
for accuracy and environmental robustness. Based on the laboratory test results a final nine 
devices were taken forward to the performance evaluation phase (Fig. 6), i.e. four respiratory 
rate devices (manual and assisted counters) and five pulse oximeters (fingertip and handheld 
devices) (112).  
Mark Two Acute Respiratory Infection timer (Model: MK2 
ARI): This manual counting device has a push button to start the 
timer, a flashing light to show it is counting and a beep sound at the 
end of 60 seconds. Battery operated, with a stated a lifespan of 2 
years. The health worker uses this device to count 60 seconds while 
manually counting the RR of the child through observation of the 
child’s chest area. In a previous study in Zambia frontline health 
workers were shown to have 46% with the reference standard, a 
medical professional counting RR manually for 60 seconds (81). 
The cost of this device is approx. $5.  The cost of this device is 
approx. $5.  Dimensions: 10mm X 20mm X 5mm. Weight: 20g 
 
Beads with ARI timer: The beads are used in conjunction with the 
ARI timer to support the health worker to count RR by moving a 
bead along each time they see a chest movement. Health workers 
have three sets of beads, one for each RR cut-off age group, each 
containing 40, 50 or 60 beads of one colour (blue in the picture) and 
five beads of another colour (red in the picture) respectively. If the 
health worker finishes counting on a red coloured bead in the picture 
they should classify the child as having fast breathing pneumonia. 
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In one study in IRC the use of beads increased the correct 
classification from 13% to 63% (36). The approx. cost for these two 
devices are $10. 
Rrate smart phone application: a smart phone tapping application 
that provides a RR count within a defined number of consistent 
breaths, which can be set from three to six, and a defined consistency 
threshold from 10 to 14%. The user taps the smart phone screen for 
each breath viewed.  Once the application has provided a RR the 
user has to verify the consistency by watching and agreeing with the 
RR of an animated child on the screen, before confirming that the 
RR is correct. In a previous study, where trained clinicians used 
RRate to count RR using videos, RRate was shown to reliably 
measure respiratory rate on average within 9.9 seconds and 
improved the efficient of counting RR (107).  The approx. cost of 
these types of phones is $80. The app is free to download. 
 
Respirometer feature phone application: is a feature phone 
application that provides a RR reading after 10, 20 breath cycles and 
60 seconds as well as categorisation of the RR (fast or normal) based 
on the age of the child. The user counts each breath by pressing a 
number button on the phone keypad. In our study the 60 second 
reading was used for all analysis as it was previously shown to be 
the best performing when the device was previously tested (54). The 
approx. cost of these types of phones is $20. The app is free to 
download. 
 
Contec fingertip pulse oximeter (Model: CMS50QB): measures 
oxygen saturation and pulse rate through attaching the device to the 
patient’s finger or toe. This device is supplied with two rechargeable 
batteries which can be used up to 300 times between charging. This 
device is recommended for use with paediatric patients due to its 
smaller size. This device is CE approved as a class IIb medical 
device. Dimensions: 46mm X 40mm X 29mm. Weight: 35g. The 
device costs approx. $40. When asked, frontline health workers in 
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the four study settings, had very low knowledge of these types of 
pulse oximeters and there performance had not been tested 
previously in these settings (37). 
Devon fingertip pulse oximeter (Model: PC600): measures 
oxygen saturation and pulse rate through attaching the device to the 
patient’s finger or toe. Supplied with a rechargeable battery and 
sized for use with paediatric patients, this device has programmable 
audible alarms.  This device is CE approved as a class IIb medical 
device.  Dimensions: 55mm X 40mm X 30mm. Weight: 80g. The 
device costs approx. $80. 
 
Lifebox handheld pulse oximeter (Model: AH-M1): a portable 
hand-held device measuring oxygen saturation and pulse rate with 
visual and audible alarms. It is both battery and mains powered and 
is supplied with a rechargeable lithium battery. It is supplied with 
re-usable adult, neo-natal and paediatric probes. This device is CE 
approved as a class IIb medical device.  Dimensions: 58.5mm X 
123mm X 28mm. Weight: 200g (without batteries) The device costs 
approx. $250. The device had previously been tested for use by 
frontline health workers in studies in Melawi (48, 113). 
 
Utech handheld pulse oximeter (Model: UT100): a portable, 
handheld device, measuring oxygen saturation and pulse rate with 
visual and audible alarms, and can be used on adults, paediatric and 
neonatal patients.  Operated with four AA batteries but it can use re-
chargeable batteries they need to be purchased additionally. It is 
supplied with an adult reusable probe as standard, but paediatric and 
neonatal reusable probes are available. This device is CE approved 
as a class IIb medical device.  Dimensions: 75mm X 135mm X 
28mm. Weight: 258g (with batteries). The device costs 
approximately $100. 
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Figure 6 Potential new RR counters and pulse oximeters tested in this thesis  
Masimo mobile phone pulse oximeter (Model: iSpO2 Rx): a 
multi-probe handheld pulse oximeter operating on an Android phone 
and is also available for iPhone. The device features low profusion 
and motion software supporting SpO2 assessments of adult, 
paediatric and neonatal patients with single and multi-use paediatric 
and neonatal probes. This device is CE approved as a class IIb 
medical device. The device is charged through the mobile phone and 
does not require an independent power source.  Dimensions: 25mm 
X 10mm X 5mm. Weight: 30g (without phone). The device costs 
approx. $250. In a previous study in Antwerp of 201 screened 
infants, with Radical-7 as the reference device, the researchers 
calculated a mean bias of -0.08% ± standard deviation of 1.76%, 
with limits of agreement of -3.52% and 3.36% (114). 
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6 RESULTS 
Although this thesis is based on three separate sub-studies, the results have been synthesised 
and are presented here under three broad themes of: 1) perceptions of frontline health workers 
and national stakeholders on pneumonia diagnostic aids; 2) performance of RR counters and 
pulse oximeters when used by frontline health workers and 3) usability, acceptability and utility 
of RR counters and pulse oximeters.   
6.1 PERCEPTIONS OF DIAGNOSTIC AIDS 
Qualitative data from sub-study I shows a range of different views on the various pneumonia 
diagnostics aids presented to the different participant groups.  
6.1.1 Pile sorting activity  
The results of the pile sorting activity are detailed in Figures 5 and 6. Overall, a much higher 
percentage of CHWs placed devices in pile 1 (able to use or scale up) compared to national 
stakeholders. Both groups rated the fingertip pulse oximeter and ARI timer highly in regards 
of usability. National stakeholders were extremely positive about the potential to scale the ARI 
timer compared to other devices (70% placed it in pile 1 and none in pile 4). CHWs had more 
varied perceptions of this device’s scalability (63% and 15% placed it in groups 1 and 4 
respectively). National stakeholders rated the scalability and usability of the smartphone pulse 
oximeter poorly (86% placed it in pile 3 or 4 for scalability and 61% did so for usability). The 
fingertip pulse oximeter’s usability and scalability was highly rated by both national 
stakeholders and CHWs.  
 
Usability: CHWs  Usability: National stakeholders 
Figure 7 Graphs depicting the pile sorting allocations of CHWs and national stakeholders (joint device 
not included due to low participant numbers) 
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Scalability: CHWs   Scalability: National stakeholders 
Figure 8 Graphs depicting the pile sorting allocations of CHWs and national stakeholders (joint device 
not included due to low participant numbers) 
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6.1.2 Themes arising from FGDs  
CHWs and national stakeholders in all countries deemed the price of pneumonia diagnostic 
aids to be a significant factor in determining future scale up (Table 5). Participants in both 
groups felt the lack of access to electricity was the greatest barrier for scale for aids requiring 
frequent recharging and stated a preference for battery powered diagnostic aids. Participants in 
both groups stated simplicity was essential to tool usability and scalability. Many national 
stakeholders and CHWs preferred familiar technology, such as the existing ARI timer or simple 
mobile phones. Participants in both groups highlighted the need for accurate aids to assist in 
classification of children with pneumonia. Devices producing automated results, such as pulse 
oximeters, the RR counting mobile phone applications and the joint device, were most 
appreciated by both stakeholders and CHWs. 
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Table 5 Overview of quotes from national stakeholders and health workers views on the usability and scalability of seven potential pneumonia diagnostic aids 
Key themes and brief 
description 
CHWs views and indicative quote National stakeholders’ views and indicative quote 
Cost of diagnostic aids x Higher cost devices would not get funded  
x Concerned they may be required to buy their own device  
x Concerned they would have to replace broken devices 
x Worried about the personal responsibility for repaying the cost if devices were 
stolen, lost or damaged.   
x Questioned who would be responsible for supplying the aids to large numbers of CHWs 
in each country.  
x Preference for less expensive devices, such as the ARI timer and the fingertip pulse 
oximeter 
x Resource allocation dilemmas – where to focus spend 
x Thief could be an issue and CHWs could be targetted 
“In our country there are about 30,000 HEWs and about 16,000 health posts. You are not 
supposed to buy for all of these. It is quite difficult. We have to think of this issue.” Ethiopian 
national stakeholder 
 
“What are the causes that our volunteers do not understand the symptoms of pneumonia, both 
for the newborn and those aged under five? In order to enable the community to know the 
symptoms, we need to spend money. So, if we have only $100, should we spend the money on 
the training of how to identify the danger signs or should we spend it on a smartphone?” 
Cambodian national stakeholder  
 
Electricity, batteries and 
charging 
 
x Participants in both groups frequently mentioned the lack of access to electricity 
in large areas of all four countries. 
x Potential difficulties if aids were highly reliant on electricity for charging 
“As to me, the health post has no electric power access and it is about two to three 
hours walking distance to get electric power. In our case, the electric power access is 
in one of the schools found in our kebele. It has a distance of two to three hours. 
x Frequent or daily charging of devices was seen as a barrier to usability and scalability. 
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Therefore, it is difficult to send the phone with students for charging at regular basis.” 
Ethiopian CHW  
x Solar panels were seen as a potential solution 
“If we have a small solar panel to charge the battery, it will be much better and much 
more convenient. We can charge the battery anywhere we want, and we can use the 
instrument for a long time.” Cambodian CHW 
Simplicity x The ARI timer’s inability to produce automated results reduced its perceived 
usability for some in Cambodia and Ethiopia and other CHWs described it being 
confusing to use.  
x Literacy level needs to be considered when developing devices 
x Ethiopia and Cambodia CHWs liked the disease classification system of the 
feature phone application, which minimised the need to interpret results using 
separate guidelines.  
x Other simplifying attributes included clear display of results in a large format for 
older CHWs with poor eyesight, and instructions and steps written in the local 
language.   
 
“Because [it] is not simple to operate such a phone by someone who is illiterate and 
also it have a lot of instructions to follow.” South Sudanese CHW  
x Devices producing automated results, such as pulse oximeters, the RR counting mobile 
phone applications and the joint device, were most appreciated by both national 
stakeholders and CHWs. 
“The fingertip pulse oximeter is easy to use because you simply insert a finger and it displays 
the readings.” Ugandan national stakeholder 
“For the simple phone, we can see the members in VHSGs (Village Health Support Groups) 
or VMWs (Village Malaria Workers) are mostly old people. Most of the members in VHSGs 
only know how to receive a phone call or can only make a call to a certain number. It is difficult 
for us to train them to use the phone.” Cambodian national stakeholder 
Accuracy x CHWs emphasised the need for accuracy when discussing problems with the ARI 
timer, which they often described as being inaccurate. 
x Participants reflected on the inherent inaccuracy of CHWs needing to count 
children’s breaths with distractions such as children crying, moving or other 
people talking, leading to the need to repeat counting multiple times. This was 
most commonly mentioned by CHWs referring to previous experiences using the 
ARI timer.   
x National stakeholders expressed concerns about the accuracy of tools that required CHWs 
to count breaths for less than one minute and then produced an automated RR. 
“The other drawback of the application (feature phone application) is it doesn’t count full one 
minute, it gives estimated number of breaths just after tenth or twentieth breath. This implies 
that it is not appropriate for irregular breathing pattern.” Ethiopian national stakeholder  
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x Both CHWs and national stakeholders liked the smartphone RR counting 
application which allows users to validate their count findings by listening to the 
calculated RR and comparing it with the child’s actual RR. They felt this increased 
its accuracy and usability.  
Durability and sustainability x Both groups of participants raised sustainability concerns, both directly and 
indirectly, during the FGDs 
x Environmental hazards that CHWs specifically mentioned included: water 
exposure; being damaged whilst carried in bags; being dropped; or being broken 
by children during the assessment. 
x National stakeholders preferred aids to be low maintenance. 
“If they can use the instruments for only one year, then the instruments are not usable anymore, 
we do not support them with more instruments. Therefore, is what we give them sustainable?” 
Cambodian national stakeholder 
 
Acceptability x Both groups preferred familiar technology, such as the existing ARI timer or 
simple mobile phones. 
x Generally, CHWs placed greater emphasis on the need for future aids to be 
acceptable to children and parents than national stakeholders. 
x They reported children would not like noisy devices (such as the ticking ARI 
timer) or those that involved attaching unfamiliar objects to their bodies (in the 
case of pulse oximeter probes). 
x CHWs preferred tools that were: small and portable; “modern” but simple to use; 
able to perform multiple functions; and able to provide automated results. They 
expressed a preference for devices producing fast results. 
 
“When I use it to count breathing, the children do not know that I count breathing and 
they may think that I am using a mobile phone. The children do not know so they are 
not frightened.” Cambodian CHW  
 
x There was resistance to the use of new technological aids, especially smartphones, by 
national stakeholders across the four countries 
“I am afraid that it is too modern and complicated so that it will be difficult to use. Our 
volunteers get used to using simple Nokia [feature] phone because it is useful for them and it 
is also very convenient to use.” Cambodian national stakeholder 
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6.2 PERFORMANCE RESULTS  
While most CHWs managed to achieve a RR count with the four different devices, the 
agreement was low for all, with a large range of mean differences of RR measurements from 
the reference standard for the four devices, from 0.5 (95% CI -2.2, 1.2) for the respirometer to 
5.5 (95% CI 3.2, 7.8) for Rrate. Performance was consistently lower for young infants (0 to <2 
months) than for older children (2 to ≤59 months). Agreement of RR classification into fast 
and normal breathing was moderate across all four devices, with Cohen’s Kappa statistics 
ranging from 0.41 (SE 0.04) to 0.49 (SE 0.05) (Sub-study IIa). 
Although all five pulse oximeters tested in field had performed well on a simulator (±2% from 
the simulator), their performance was more varied when used on real children by frontline 
health workers. The handheld pulse oximeters had greater overall agreement with the reference 
standard (-0.6% SpO2; 95% CI -0.9, -0.4 to -3.0% SpO2; 95% CI -3.4, -2.6) than the finger-
tip pulse oximeters (-3.9% SpO2; 95% CI -4.4, -3.4 to -7.9% SpO2; 95% CI -8.6, -7.2). This 
was particularly pronounced in the younger children, where handheld had -0.7 (95% CI -1.4, -
0.1 to -5.9 (95% CI -6.9, -4.9) agreement, compared to fingertips, which had -8.0 (95% CI -
9.4, -6.6 to -13.3 95% CI -15.1, -11.5) agreement. While all devices under estimated SpO2 
readings compared to the reference standard, the finger-tip devices were particularly more 
likely to under estimate SpO2 and subsequently over diagnose hypoxemia in the children 
assessed. First level health facility workers had better agreement with the reference standard 
(N=0.32; SE 0.05 to N=0.86; SE 0.07) for all five devices, when compared to CHWs (N=0.15; 
SE 0.02 to N=0.59; SE 0.03) (Sub-study IIb).  
In Sub-study IIa, the differences in RR counts between CHWs using the four RR counters and 
the reference standard, plotted against the average RR of the two measures, is illustrated in the 
Bland Altman plots (Figure 7-10). These show large variation in readings for all four RR 
counters, but especially in the younger children. The ARI with beads plot (Figure 7) shows a 
mean difference of -1.9 bpm, and limits of agreement (LOA) from -19.0 bpm to 15.1 bpm, and 
most variation seen in the older age group. The MK2 ARI plot (Figure 8) showed a mean 
difference of -0.6 bpm, and LOAs from -25.4 to 23.9 bpm. The plot also shows that for the 
older children with lower breath rates MK2 ARI over-counted RR, whereas for older children 
with higher breath rates MK2 ARI under-counted RR. In the Rrate plot (Figure 9), the mean 
difference was 5.5 bpm with wide LOAs ranging from -24.2 to 35.2 bpm, with more variation 
in the younger children with higher breath rates. The Respirometer (Figure 10) had a mean 
difference of -0.5 bpm and the LOAs were wider than the other device, ranging from -28.6 to 
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27.5 bpm. Also this device had more variation in the higher breathing rates, with the younger 
children being over-counted and the older children under-counted. 
In sub-study IIa, agreement of the RR classification into normal or fast breathing for CHWs 
and the reference standard measurements varied widely between the four RR counters, 
especially for the young infants. The MK2 ARI had the highest N statistic, both overall (0∙49; 
SE 0∙05) and for each of the two age groups, 0∙26 (SE 0∙08) and 0∙62 (SE 0∙07) respectively 
(Table 6). 
In sub-study IIb, using the standard WHO cut-offs (< 90%) to classify the oxygen saturation 
into hypoxaemia or non-hypoxaemia, there was more variability in the agreement between the 
reference standard and the test devices in the younger children than the older children as 
highlighted by the Kappa statistic (N) data (Table 6). The Contec fingertip pulse oximeter had 
poor agreement across both age groups with the reference standard (N=0.01; SE 0.01 – N=0.25; 
SE 0.03). The Devon finger-tip pulse oximeter had fair agreement overall (N=0.38; SE 0.03). 
The Lifebox handheld pulse oximeter had poor agreement (N=0.31; SE0.05) in the younger 
children and had moderate agreement (N=0.51; SE0.03) in the older children. The Utech 
handheld pulse oximeter had poor agreement (N=0.2; SE 0.05) in the younger children and 
moderate agreement (N=0.57; SE 0.03) in the older children. The Masimo phone pulse oximeter 
had the best agreement of all five pulse oximeters (N=0.67; SE 0.03) with moderate agreement 
(N=0.5; SE 0.06) for the younger children and good agreement (N=0.71, SE 0.03) for the older 
children. 
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Figure 9 Bland Altman plot for ARI timer with beads n=87 
 
Figure 10 Bland Altman plot for the MK2 ARI timer, n=169 
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Figure 11 Bland Altman plot for the RRate, n=158 
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Figure 12 Bland Altman plot for the Respirometer, n=312 
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Table 6 Performance of RR timers and pulse oximeters when compared to a reference standard 
Agreement measurement 
Beads and ARI  
(n=172)  
MK2 ARI  
(n=322) 
RRate  
(n=304) 
Respirometer  
(n=626) 
Contec 
(n=1120) 
Devon  
(n=1124) 
Lifebox   
(n=1186) 
Utech  
(n=1186) 
Masimo  
(n=1186) 
 ±2 bpm or SpO2%  
%  
n/N 
35 
60/172 
32 
104/322 
34 
102/304 
26 
165/626 
31 
303/1120 
47 
454/1124 
56 
609/1186 
58 
596/1186 
68 
784/1186 
Mean difference or ‘bias’  
(95% CI) 
-1.9  
(-3.8, -0.2) 
-0.6 
(3.8, -0.2) 
5.5 
(3.2, 7.8) 
-0.5 
(-2.1, 1.2) 
-7.9 
(-8.6, -7.2) 
-3.9  
( -4.4, -3.4) 
-2.7  
(-3.0, -2.3) 
-3.0  
(-3.4, -2.6) 
-0.6  
(-0.9, -0.4) 
Kappa value 
(Standard error) 
0.41 
(0.07) 
0.49 
(0.05) 
0.44 
(0.06) 
0.41 
(0.04) 
0.19 
(0.02) 
0.38 
(0.03) 
0.48 
(0.03) 
0.46 
(0.03) 
0.67 
(0.03) 
Positive percent agreement  
(95%CI) 
44 
(29.5-58.8) 
53 
(41.9-63.5) 
71 
(59.1-80.3) 
58 
(51.3, 64.9) 
89 
(80.0-94.8) 
83 
(72.4-90.1) 
87 
(77.6-92.8) 
88 
(79.4, 94.2) 
84 
(74.5, 90.0) 
Negative percent agreement 
(95% CI) 
93                      
(86.7, 96.6) 
92 
(87.6, 95.0) 
78 
(72.4, 83.5) 
82 
(78.3, 85.9) 
64 
(60.3-66.6) 
84 
(81.0, 85.9) 
88 
(85.7, 89.9) 
87 
(84.3, 88.8) 
96 
(94.1, 96.6) 
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6.3 USABILITY AND ACCEPTABILITY 
6.3.1 Usability 
In sub-study III, 87.6% of health workers who used the RR counters (Fig.11) and 70.7% of 
health workers using pulse oximeters achieved full procedure adherence scores (Fig. 12). 
Across all four RR counters, health workers were successful in ensuring the child was in the 
correct position with a visible chest and lower abdomen, turning on devices, and identify and 
circle the highest reading for records. Data also showed a lower proportion for users correctly 
diagnosed a child with fast breathing using the manual device the MK2 ARI (88.1%) compared 
to those using the assisted devices, 90.1% for respirometer, 94.6% for Rrate and 98.1% for ARI 
and respiratory beads users. In using the pulse oximeters, two devices had a lower correct 
proportion when classifying low oxygen levels for both Contec (84.9%) and Utech (77.2%).  
 
 
*For beads and ARI this means selected the correct set of beads 
Figure 13 Proportion of tasks performed correctly for respiratory rate counters 
MK2 ARI ARI & Beads Rrate Respirometer
Ensured child is calm 93.4% 100.0% 94.6% 98.9%
Ensured chest and lower abdomen
visible 99.5% 100.0% 99.7% 100.0%
Successfully turned device on* 100.0% 98.0% 99.7% 100.0%
Took two readings 95.6% 100.0% 98.1% 99.7%
Circled highest reading 99.2% 99.3% 99.7% 99.7%
HW classified fast breathing 88.1% 98.1% 94.6% 90.1%
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*Only applies to handheld pulse oximeters 
Figure 14 Proportion of tasks performed correctly for pulse oximeters 
 
The highest mean adherence score recorded for a RR counter was for the ARI and beads 
(mean=5.95, SD=0.29), followed by the Respirometer (mean=5.87, SD=0.38), with strong 
evidence of a small but significant different between individual device scores (p<0.001). 
Overall, the assisted RR counters had higher mean adherence scores than the manual MK2 ARI 
timer.  
Table 7 Procedure mean adherence scores, standard deviations, change in mean scores, 95% confidence 
intervals and p values for RR counters (n=1,291) 
 
N 
Mean 
score 
(μ) 
Standard 
deviation 
(σ)  
Change in 
mean score 95% CI p-value 
Device 
name 
MK2 ARI Timer 395 5.68 0.85 0  
<0.001 
Beads and Timer 150 5.95 0.29 0.28 (0.17, 0.41) 
Rrate  372 5.82 0.61 0.14 (0.05, 0.22) 
Respirometer 374 5.84 0.38 0.19 (0.10, 0.28) 
Cadre CHW 1044 5.85 0.35 0  <0.001 
FLFHW 247 5.62 0.52 -0.22 (-0.31, -0.14) 
Country Ethiopia 374 5.69 0.46 0  
<0.001 South Sudan 375 5.97 
0.37 0.29 (0.20, 0.37) 
Cambodia 167 5.52 0.52 -0.16 (-0.26, -0.06) 
Uganda 375 5.89 0.47 0.20 (0.11, 0.28) 
Device 
type 
Non Automated 396 5.68 0.26 0  <0.001 Assisted 895 5.86 0.34 0.18 (0.11, 0.25) 
2-12 months 401 5.71 0.54 -0.08 (-0.23, 0.07)  
12-59 months 818 5.86 0.64 0.07 (-0.07, 0.22) 
 
Contec Devon Lifebox Utech Masimo
Ensured child is calm 100.0% 98.5% 100.0% 100.0% 91.7%
Ensured upper and lower
limb are exposed 100.0% 100.0% 98.1% 100.0% 100.0%
Successfully turned device on 100.0% 100.0% 98.1% 100.0% 100.0%
Selected correct probe* 98.4% 96.2% 98.6%
Checked probe sensor* 94.2% 92.3% 97.2%
Connected probe sensor* 100.0% 100.0% 100.0%
Attached light and sensor* 98.0% 98.1% 98.6%
Identified correct reading 100.0% 100.0% 100.0% 100.0% 100.0%
Took two readings 97.9% 96.8% 96.1% 93.9% 98.6%
Circled lowest reading 97.9% 98.0% 98.0% 95.6% 98.6%
HW classified low oxygen level 84.9% 89.6% 89.1% 77.2% 97.1%
80%
82%
84%
86%
88%
90%
92%
94%
96%
98%
100%
Pr
op
or
tio
n 
ta
sk
s c
om
pl
et
ed
 co
rr
ec
tly
  
   52 
Table 8 Procedure mean adherence scores, standard deviations, change in mean score and 95% confidence intervals and p values for pulse oximeters 
 
 
Fingertip pulse oximeter mean procedure adherence scores 
(N=120) 
Handheld pulse oximeter procedure adherence score 
(N=184) 
 
N Mean Change 
in mean 
score 
95% CI p-value N Mean Change in 
mean score 
95% CI p-value 
Device Name Contec Finger 53 6.4 0   
0.55 
          
Devon Finger 
67 6.61 
0.2
1 (-0.48, 0.91) 
    
    
  
Lifebox Handheld           55 10.10 0 
 
0.09 Utech Handheld           57 9.61 -0.49 (-1.28, 0.29) 
Masimo Handheld           72 10.44 0.33 (-0.42, 1.08) 
Cadre CHW 105 6.51 0   
0.56 
148 9.97 0   
0.17 FLFHW 15 6.67 -0.3 (-1.35, 0.74) 36 10.52 0.54 (-0.23, 1.33) 
Female 65 6.75 0.63 (-0.04, 1.32) 94 10.38 0.61 (-0.01, 1.22) 
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6.3.2 Acceptability 
In sub-study III data from the 40 key informant interviews with frontline health workers 
showed that they found the new RR devices more accurate, easier to use and faster than their 
current standard practice in supporting them to make a diagnosis (Table 9). They further 
reported finding the pulse oximeters easy to use, but did find them more difficult to use on 
younger children. They also reported that the new devices gave them more confidence in their 
role diagnosing pneumonia in children under five. Health workers asked that these types of 
new devices be introduced at scale to support them in their work. 
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Table 9 Overview of research themes in relation to health worker and national stakeholder views on the scalability and usability of seven pneumonia diagnostic aids 
Key themes Key findings Indicative respondent quote 
 
Perceived effectiveness 
x New diagnostic aids was an improvement in relation to their current standard 
practice, the ARI timer  
x Preferred the assisted devices (ARI with beads, Respirometer and Rrate) over the 
manual MK2 ARI  
x New diagnostics aids more accurate, easier to use and faster in supporting them to 
make a diagnosis, even of the pulse oximeters, which they had not used before. 
x Some found it difficult to use the pulse oximeters on younger children  
“The device I trained helped me in diagnosis of pneumonia very well, because the 
previous ARI timer has sound that disturbs children but the current one is no sound 
and child disturbance.” [HEW in Ethiopia] 
“UTECH is the easiest device to use as it does require connection of the sensor 
and it gives instant results when inserted onto the finger of the child unlike 
respiratory beads that takes long time to get the diagnosis at the end”. [CDD in 
South Sudan] 
Intervention coherence x Health workers mainly felt they understood how to use the RR devices after their 
training.  
x They felt that their understanding of the pulse oximeter devices improved over time 
and with practice. 
“I preferred both pneumonia diagnostic devices (RR smart phone and Massimo 
smart phone) because R.R smart phone counts and shows the respiratory rate and 
Masimo smart phone shows oxygen concentration of the blood”. [HEW in 
Ethiopia] 
Self-efficacy x New dignostic aids gave them more confidence in their role  
x Increased confidence in their role encouraged increased care seeking behaviours 
 
“I enjoyed treating the children thanks to the fame Malaria Consortium brought 
me. It has provided me with all that I need. Pneumonia cases are very many here 
in the community and Malaria Consortium has stood up to fight against the 
encroaching disease”. [CDD in South Sudan] 
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      Burden 
x New disgnostic aids to be more user friendly than the devices they previously used  
x New diagnostic aids helped them more in their jobs and allowed them to see more 
sick children 
“The device (MK2 ARI) I trained helped me in diagnosis of pneumonia very well, 
because the previous ARI timer has sound that disturbs children but the current 
one is no sound and child disturbance”. [CDD in South Sudan] 
 
   Scalable 
x New diagnostic aids should be introduced at scale to support their work diagnosing 
pneumonia 
x Some did mention that the pulse oximeters needed a higher level of skill and 
particularly people who have a higher level of literacy and numeracy. 
“Yes, it is better to introduce (MK2 ARI) to all. Currently it is few of us who took 
training and are working on this”. [HEW in Ethiopia] 
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7 DISCUSSION 
7.1 MAIN FINDINGS 
This thesis aims to identify and evaluate the most accurate, acceptable and user-friendly 
respiratory rate timers and pulse oximeters for diagnosis of pneumonia symptoms in children 
by frontline health workers in low-resource settings. Frontline health workers were able to use 
the nine test devices to measure RR and oxygen saturation in children under 5, but will variable 
performance, and found it more difficult to get a successful measurement in younger children. 
Frontline health workers were better supported by assisted RR counters, such as Rrate and 
respirometer, compared to their standard practice diagnostic aid, MK2 ARI timer. Handheld 
pulse oximeters with multiple probes performed better than finger-tip pulse oximeters, 
especially in younger children. The views of different stakeholder groups should be considered 
when looking to take these types of pneumonia diagnostic aids to scale. Our findings from both 
sub-study I and III show that both frontline health workers and national stakeholders want 
simple and uncomplicated, affordable diagnostic aids, this must be considered as part of the 
development process undertaken by device manufacturers. 
7.2 PNEUMONIA: A MAJOR CHILD KILLER WITHOUT AN AGREED 
DEFINITION  
While there is still no globally agreed clinical definition for pneumonia (115) or any test to 
show if the infection is bacterial or viral, RR continues to be the primary method for 
diagnosing pneumonia in children with cough and/or difficulty breathing in low resource 
settings, with sensitivity ranging from 76-81% and specificity from 60-89% (116-119). Studies have 
also shown relatively high sensitivity (75—81%) and specificity (81—83%) of CHWs classification 
of fast breathing in children using the ARI timer (5, 33, 81). However, the usefulness of including 
other clinical signs, such as fever and work of breathing, in the clinical management algorithms for 
childhood pneumonia is ongoing, driven by changes in the epidemiological context of infections (11, 
120), technical advances for prevention and treatment (121), and further evidence becoming available 
on biomarkers (122), but as of yet none have been proved conclusive to replace RR (120, 123). Work 
is also being undertaken to harmonise and redesign the existing WHO guidelines (124), but there is 
no suggestion of the removal of respiratory rate from the IMCI or iCCM algorithms. Use of pulse 
oximetry screening for detection of severe pneumonia, and host biomarker point of care tests (POCTs) 
like C-reactive protein (CRP) and procalcitonin (PCT) for detection of bacterial pneumonia, are being 
investigated (123, 125, 126). While a study in Tanzania recently showed that the use of POCTs in a 
modified electronic case management algorithm resulted in a 49% lower relative risk of clinical 
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failure compared to routine care while reducing antibiotic use, the use of POCTs in primary care is 
only recommended for higher risk children, to avoid over referral. For example, the positive predictive 
value of the CRP test to diagnose radiological pneumonia in children with fever and cough drops 
from 54% to 32% when fast breathing is removed from the algorithm(120, 127). Hence, respiratory 
rate counting will continue to play an important role, along with assessing for danger and referral 
signs, even when POCTs become available in routine care, and the development of improved 
diagnostics aids for facilitating improved RR counting should continue to be a priority until further 
evidence is presented. However, as highlighted elsewhere (128), this should not stop continued 
investigations on other predictive signs and symptoms of pneumonia, such as work of breath, and 
other combinations of signs and symptoms and point of care markers (123, 129).  
There is also a need for further clarity in the definition of symptoms currently used to 
presumptively diagnoses pneumonia. While RR has been included in diagnostic algorithms 
since the 1980s (14), little work has been done to accurately define what a breath is, and 
develop a standardised protocol for training how to consistently count RR. Given the 
variability we saw in the RR measurements in all four devices in sub-study IIa, with ±2 bpm 
agreement with the reference standard ranging from 26 to 35% of measurements, this work 
would really support future development of improved RR counters.  
 
7.3 THE LACK OF APPROPRIATE DIAGNOSTICS FOR FRONTLINE HEALTH 
WORKERS 
While the need for improved diagnostic aids was clear from sub-study I, where both CHWs 
and national stakeholders were receptive to appropriate and supportive new RR counters and 
pulse oximeters, our studies have shown there is a need for further development in pneumonia 
diagnostic aids which will adequately support frontline health workers to better manage 
pneumonia in children under 5. Both health worker and national stakeholder respondents 
highlighted that cost. Complexity and level of maintenance required were key factors when 
introducing new RR counting aids. This is similar to the views expressed by health workers 
in other studies in Cambodia and Malawi when asked about the introduction of similar 
technologies such as pulse oximetry (84, 130). It has been suggested that the inclusion of 
pulse oximetry in the management of pneumonia in resource poor settings can improve health 
outcomes. In 2014 the WHO amended their guidelines on facility based management of 
pneumonia to include the use of pulse oximetry when pulse oximeters are available (29), but 
in many high burden pneumonia countries, such as Ethiopia and Nigeria, the introduction of 
pulse oximetry also at community level has been advocated for (71, 131). 
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7.3.1 Issues with current diagnostic aids 
Sub-study II shows that while CHWs using either of the four different RR counters were able to obtain 
a RR measurement from children in the majority of cases, the agreement of their measurements with 
the reference standard was low for all of the four devices tested. As in previous studies in Zambia and 
Uganda, where expert clinicians were used as the reference standard to assess agreement with CHW 
measurements (33, 81), our study also shows a lot of variability between the CHWs and our automated 
reference standard RR count. Our data shows that it was especially difficult for CHWs to obtain an 
accurate count (±2 breaths) in young infants, in which only 8% to 20% of the assessments were in 
agreement with the reference standard, regardless of the RR counter used. The agreement between 
the tested devices and the reference standard was significantly higher for older children, ranging from 
30 to 40% in the 2 to ≤59 month olds, which is also reflected in a previous study in Zambia where 
decreased RR variability was seen in older children. There was no significant difference in 
performance between the four devices tested and, unexpectedly, the three improved manual devices 
tested in our study (beads with ARI timer, RRate and the Respirometer) all showed lower agreement 
than studies of completely manual counters, where 46% of observations were ±2 breaths from the 
reference in Zambia, and 64% in Uganda (33, 132). This further affirms our findings that counting 
RR manually, with breaths being difficult to see and count being hard to maintain without 
interruptions that require the count to be repeated, is a difficult procedure to do accurately and more 
is required of a device than simply supporting the health workers to keep count of the number of 
breaths a patient takes over 60 seconds. In sub-study III the mean adherence scores for the RR 
counters reaffirmed the difficulties health workers have with manual counting devices as the mean 
scores for the manual MK2 ARI was significantly lower than the assisted devices.  
Similarly, in sub-study IIb device performance in all five pulse oximeters in relation to 
agreement with a reference standard varied largely and did not reflect the minimal differences 
seen when devices were tested in a controlled laboratory environment. This showed the 
importance of testing devices in the field and not relying on performance results from 
simulators or laboratory testing alone, which is often the only evidence presented for CE 
mark accreditation. The Masimo mobile phone pulse oximeter had the best overall 
performance across all measures and in both age strata of the children the device was tested 
on. This may be due to the motion signal processing techniques incorporated in Masimo pulse 
oximeters which attempts to reduce motion artefact (133), which may be particularly 
important when using these devices on moving children.  
Furthermore, sub-study IIb showed that handheld pulse oximeters with multiple probes had 
higher agreement with the reference standard than the fingertip pulse oximeters and show 
similar levels of performance as previous studies on similar handheld pulse oximeters with 
multiple probes (85). This reflects the fact that these devices allowed more precise 
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measurements, most likely a result of their paediatric and neonatal probes. While this has 
been highlighted in the literature in relation to safer surgery (134, 135), it is also vital to 
consider when using devices on children under two months. As can be seen in our data both 
figure tip devices had very poor performance in this age group, which could likely be due to 
poor probe fit. This has also been highlighted in recent studies in Malawi and Bangladesh, 
where health workers recommended that devices have multiple sizes of probes for different 
ages (48, 85). Finger-tip devices consistently recorded lower readings compared to the 
reference standard in both user groups and age strata. This would mean that these devices 
would underreport on SpO2 measurements if used as a screening device for severe 
pneumonia on children and could lead to over diagnosis of cases of severe pneumonia in the 
children screened and over referral of “hypoxaemia” to higher level health facilities.  With 
regards to classification into hypoxaemia or non-hypoxaemia, there were no significant 
differences in PPA, with the confidence intervals overlapping for all devices. However, there 
were large differences in NPA, with Masimo well outperforming all the other devices, and 
Contec performing worse than all other devices, again reflecting the issue with the figure-tip 
devices under reporting SpO2. These results reflect the results of another study of similar 
types of fingertip pulse oximeters, which saw inaccurate readings and large errors, and 
suggests these devices should not be used as diagnostic tools in these settings (136).  
The data in sub-study II showed the first level health facility workers performed better using 
the pulse oximeters than community health workers. While in a previous qualitative study 
both types of health workers had not had previous exposure to pulse oximetry (84), other 
recent studies conducted in hospital settings in Nigeria showed that pulse oximetry was a 
new practice for all health workers (87). Key to the scale up of pulse oximetry in these 
settings is to further understand the drivers for adoption as the Nigeria study showed that 
while enhanced knowledge and skills are necessary, they are not sufficient on their own to 
drive usage of these devices.  
Data from sub-study III did show that for the RR devices, health workers were better able to 
classify fast breathing when using assisted devices, rather than their standard practice (MK2 
ARI timer). The usability data for the pulse oximeters was more mixed, but in general it 
reflected that health workers could more easily classify hypoxemia when using handheld 
pulse oximeters. There has been an increased focus on pneumonia diagnostic aids since the 
inception of this thesis, including the UNICEF Acute Respiratory Infection Diagnostic Aid 
(ARIDA) and Scaling Pneumonia Response Innovations (SPRINT) projects (137, 138), and 
the recent UNITAID fever diagnostics grant (139). Diagnostic aids incorporated in mobile 
phones continue to be an emerging technology and should continue to be evaluated for use 
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in resource-poor settings, especially given the current focus on developing multimodal and 
mHealth decision support platforms such as Medsinc and Feebris (140, 141). As previously 
advocated for (142), it is vital that robust health care technology assessments are conducted 
for these new technologies going forward, in order to ensure adoption and use in routine care. 
7.4 THE BARRIERS TO ACCURATELY COUNTING RR IN CHILDREN UNDER 
FIVE 
While health workers in sub-study IIa and III showed they could get a respiratory rate count 
using the four different RR counters most of the time, it proved challenging to accurately 
count the RR of children under 5 (143). Similarly, when comparing the classification of fast 
breathing by all four RR counters to the reference standard in Sub-study IIa we saw moderate 
Kappa values (N=0.41 to 0.49). This reflects similar results in previous studies in Uganda 
(N=0.665) (5), Zambia (N=0.58) (81) and Malawi (N=0.35) (144). Manually counting RR has 
well documented issues with accuracy and reliability, such as movement of the child 
distorting the count, mistaking movement as breaths, distraction of the health workers and 
the inherent variability of RR over time (116, 145, 146). Ideally, all of these challenges need 
to be addressed in developing an improved RR counter which could better support health 
workers to achieve an accurate RR count in these settings. Similarly, the definition of an 
accurate RR count needs to be considered and a consensus view reached. Historically, the 
accepted accuracy threshold recommended for training was ±2 bpm, and this continues to be 
suggested (147). However, given the results we have seen in sub-study II, we would suggest 
that this threshold needs to be reconsidered.   
7.5 THE LACK OF AGREED STANDARDS FOR EVALUATION DIAGNOSTIC 
AIDS 
In designing this thesis project we looked at the available literature for similar studies 
previously conducted. The literature search showed there is no consensus view on the most 
appropriate methods, gold standard or reference standard or metrics to use for these types of 
performance evaluations of respiratory rate or pulse oximetry devices. As highlighted in other 
papers, a consensus view on these would help to improve the generalisability of future 
evaluations of pneumonia diagnostic aids (40). 
7.6 REFERENCE METHODS 
The issues with reference standards for RR performance evaluations has been recently 
discussed in the literature recently (51, 148). The challenges of the variability of human 
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references, plus the ability of new devices to be potentially more sensitive than human counters, 
have both been highlighted. In sub-study IIa&b we used two different reference standards, a 
continuous monitor and an expert clinician, both providing reference RR measurements. This 
decision was based on the outcome of a technical consultation on pneumonia diagnostics 
evaluations that was held in Geneva in May 2014 (149). The recommendation was based on 
the fact that there is no gold standard for RR and therefore it would be more robust to use two, 
imperfect reference standards. We did see large amounts of variability in our reference 
standards, and while these data is not presented in this thesis, we are finalising a publication on 
these data (150), documenting the learnings from two recent RR performance studies we 
conducted, and presenting some potential solutions and learnings for future RR performance 
studies. 
7.7 STANDARD METRICS FOR PNEUMONIA DIAGNOSTIC PERFORMANCE 
EVALUATIONS 
While there is consensus of the need to rigorously evaluate the performance of diagnostic aids before 
being introduced at scale (40), there is little consensus on the most appropriate metrics to use when 
evaluating the performance of pneumonia diagnostic aids. In a recent systematic review, where 18 
performance studies of pneumonia diagnostic aids were evaluated a wide variation in the statistical 
methods for comparing performance was found (40). When looking at appropriate statistical measure 
for RR agreement studies it is important to note that mean difference (bias) is often lower than root 
mean difference (RMSD) because it does not account for the positive and negative variation in RR 
measurements. However RMSD should not be used in these agreement studies as it does not account 
for both random and non-random error (51). Therefore we would recommend using the Bland Altman 
method, as we did in our performance evaluation of the RR counters (151), as it reflects both.  
7.8 THE CHALLENGE IN CONDUCTING MULTI-COUNTRY LARGE SCALE 
EVALUATIONS 
In designing this study, four individual countries were elected, based on their varied health 
systems and the different demographics of the frontline health workers in each. However, in 
sub-study II and III there was no significant difference in performance, usability or 
acceptability across the four countries where these sub-studies were conducted. To maintain 
consistency across the four research countries a strong focus on standardisation on each sub-
study, was key in achieving quality data and output. Standardisation was largely achieved 
through multi-country protocol design workshops, where all country teams came together to 
co-create the protocols and standard operating procedures that were used in each of the sub-
studies (152). The implications of not having a consensus view on evaluation methods, 
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reference standards or standard metrics, is that it will be very difficult to provide the evidence 
around clinical efficacy and cost-effectiveness that is needed for governments and donors to 
be able to take the decision to introduce these new devices at scale. 
7.9 IMPLICATIONS FOR SCALING PNEUMONIA DIAGNOSTIC AIDS 
Despite pneumonia being a leading cause of death and disability in the world and the leading 
infectious disease killer, responsible for an estimated 2.6 million deaths in 2017 (153), the 
continued lack of action on pneumonia will prevent many countries from achieving the new 
sustainable development health goals by 2030 (154). Despite the high burden of pneumonia 
in children under five, international development assistance for pneumonia has never pushed 
beyond 2% of all research investments in health (Fig. 13) (155). 
 
Figure 15 Cumulative research investments in global health from 2000 until 2015                     
(Source: Research Investments in Global Health, 2018) 
While data in sub-study I and III show national stakeholder and frontline health worker felt 
need for rapid scaling of improved pneumonia diagnostic aids, there is still a lack of clarity 
from the global community on where the development focus should be.  The role of a global 
movement to focus advocacy, research and development activities will be key going forward 
to provide forums to build consensus views on research and development priorities for 
pneumonia diagnostic aids. Every Breath Counts (EBC) is one such group, which was formed 
in 2018 as the first public-private partnership to support national governments to end 
preventable child pneumonia deaths by 2030, recognizes the need for innovation to improve 
pneumonia case management in children under five in primary health care settings. 
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7.10 CONCLUSIONS 
Of the four RR devices tested in sub-study IIa and III, none performed well in the hands of 
frontline health workers. While frontline health workers were more supported by assisted RR 
counters rather than the manual counter, which is often standard practice (the MK2 ARI 
timer), none performed well enough to be considered replacement diagnostic aids. Therefore, 
as the MK2 ARI is the most affordable option, and as most CHWs are more familiar with its 
use, it could replace the original ARI timer. Respiratory rate counting will continue to play an 
important role, along with assessing for danger and referral signs, even when POCTs become 
available in routine care, and the development of improved diagnostics aids for facilitating improved 
RR counting should continue to be a priority until further evidence is presented. Stakeholder 
engagement throughout the development process is critical, in order to ensure new diagnostic aids 
fully meet the needs of end users, caregiver and the broader health system they support. 
Of the five pulse oximeters tested in sub-study IIb and III, all performed consistently when 
tested on simulators in the laboratory. However, performance was much more varied when 
tested by frontline health workers in the field. Handheld pulse oximeters with multiple probes 
perform better when used by frontline health workers to measure oxygen saturation in 
children under five years of age. This should be considered when making procurement 
decisions for these settings. First level health facility workers had better agreement with the 
reference standard when using the five pulse oximeters in children under five. Again this 
needs to be considered when looking to introduce pulse oximetry in these types of health 
systems. While frontline health workers and national stakeholders requested that new 
technologies be developed and introduced, they were clear that any new technology should 
be easy to use, robust and affordable to take to scale. 
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8 IMPLICATIONS FOR FUTURE POLICY, PRACTICE AND 
RESEARCH 
x To maximise the effectiveness of case management of pneumonia, it is recommended 
that automated, easy to use, robust and affordable RR diagnostic aids for assessing 
symptoms of pneumonia for use in remote, resource poor settings are developed and 
tested.  
x Handheld pulse oximeters with multiple probes, suitable for children of all ages, need 
to be considered when planning scale up of this technology in resource poor settings. 
x Future studies should consider a robust, tailored approach which allows direct 
comparison between the performance measurement of the test device and the reference 
standard. 
x A full health technology assessment methodology should be followed, and while 
laboratory testing is seen as valuable it should not replace field testing with frontline 
health workers in routine practice. 
x There is a need to validate the reference standards available to establish the 
performance of new devices. The reference standard and test device measurements 
should be taken simultaneously and use the same measurement methodology.  
x Agreement measures should reflect the true performance of the test device, including 
both under and over estimation of the measurements compared to the reference 
standard. Alternative study designs looking at clinical outcomes could also be 
considered in the absence of a robust RR reference standard. 
x The different views of all key stakeholders need to be considered when mapping 
research and development priorities for pneumonia diagnostic aids, and public-private 
partnerships are a good way of creating opportunities to document a consensus view of 
these. 
x Future data is required on the utility of introducing pulse oximetry at the community 
level. 
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9 METHODOLOGICAL CONSIDERATIONS 
Overall study design 
A strength of this thesis is the use of both quantitative and qualitative methods in a mixed 
methods hybrid design. Hybrid designs are those that blend design components of effectiveness 
and implementation research (156). The benefit of these types of designs include shortening 
the timelines for data collection by conducting the research concurrently and more useful and 
complete information for decision makers. Qualitative methods in sub-study I and III provided 
insight into frontline health worker views on device acceptability and suitability to scale as well 
as national stakeholder views on their usability and scalability. Quantitative methods in sub-
study II a&b documented the performance of the nine test diagnostic aids, compared to 
reference standards. In using both quantitative and qualitative methods, the thesis was better 
able to explain the performance of the different diagnostic aids, and link this to the more 
qualitative usability and acceptability data.   
 
Focus group discussions and interviews 
Sub-study I used focus group discussions to collect data from both frontline health workers and 
national stakeholders. FGDs are useful to capture trends in opinion about the topic of interest. 
One limitation can be participant inhibition, where the group setting can hinder the active 
participation of individuals and affect data quality and depth (99). We ensured we minimised 
the possibility of this by have separate FGDs for each study population group, thereby creating 
a supportive, peer-led environment to encourage better participation and engagement. 
 
The challenges with pneumonia diagnostic aid performance evaluations 
There are a number of specific challenges in conducting performance evaluations where 
different classes of devices are included, such as in Sub-study II a & b, which included both 
RR counters and pulse oximeters. The first being selecting the most appropriate reference 
standard. In sub-study II a&b we selected an automated RR reference standard (Masimo Root 
patient monitoring and connectivity platform with ISA CO2 capnography and Radical 7 pulse 
oximeter). This reference was selected due to its portability and suitability for these settings, 
and has been validated in paediatric and neonatal populations (157, 158) but not necessarily in 
LMIC settings. The device used nasal cannulas to capture CO2 from patients and therefore this 
method could have challenges in young children, as they might be less receptive to the nasal 
cannulas. As one of the test pulse oximeters was also from Masimo the reference standard 
could be calibrated the same way as this test device, resulting in positive bias to the results. 
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Another challenge with a multi-device trial is timing, i.e. how to time data collection correctly 
and align with the development timelines of new diagnostic aids to ensure including the most 
relevant and innovative devices in data collection. For sub-study II a&b we had over 180 
devices in our initial long list and landscape analysis (110). However, more than 50% of 
relevant devices were not available when we conducted our data collection, and therefore could 
not be included in the evaluation. Finally, maintaining consistency across the four research sites 
was challenging in all three sub-studies. Each country had very different settings and therefore 
each sub-study had to be designed and implemented to account for this. For each sub-study a 
protocol design workshop was held were all four countries came together and ensured that the 
protocol was co-created, with the specific requirements of each research site and study 
populations accounted for. Similarly, all study materials, training guides and job aids were co-
created by all teams, translated into local languages and pre-tested before data collection in all 
three sub-studies. In sub-study II and III all health workers were trained and standardised in the 
same way and had to participate and pass a competency assessment before participating in data 
collection. 
Generalisability and transferability of the results 
A limitation of sub-study II a&b was that severely sick children were excluded for safety when 
designing the study, which resulted in a more limited spectrum of RR measurements and 
oxygen saturation levels in the study sample (i.e. less children with high RR measures and low 
SpO2 levels). To account for this, we conducted laboratory testing of the pulse oximeters before 
the hospital evaluation to test the accuracy of the pulse oximeters at a range of different oxygen 
saturation levels, using simulators. 
For sub-study II a&b busy hospitals were selected in each of our four research sites in order to 
ensure that we achieved the required sample of 1,720 children. This is not the routine work 
environment for the majority of the community-based health workers or health works that we 
included in the study. However, the patient load in the CHWs’ home setting would be too low 
to allow for recruitment of the required sample size. To mitigate for this bias, we also conducted 
field work also in the routine work setting of the health workers to allow data to be collected 
on the usability, utility and acceptability of these devices in the routine care setting of health 
workers in the four research locations, and this will be presented elsewhere. 
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11 APPENDIX 1 DEVICE ATTRIBUTES  
No. Attribute Description 
1 Usability - ease of use 
 
Easy for CHWs to use the device i.e. can apply it appropriately e.g. switch on 
the device, select the correct settings, complete the assessment to get a result 
2 High level of decision support Allows the community health worker to detect the symptoms of pneumonia 
without the need for decision making from them 
3 Automation of diagnosis Automatically provides the CHW with a diagnosis of pneumonia symptoms  
4 High accuracy of 
measured/calculated result  
The device consistently provides an accurate measure of the result tested for 
– either RR or PO 
5 No or little literacy and 
numeracy required 
The device only requires a very low level of literacy and/or numeracy to be 
operated by the CHW  
6 No or little training required The CHW only requires minimal amounts of training to be able to use the 
device effectively to detect the symptoms of pneumonia  
7 No or little familiarity with 
technology required 
The CHW does not need any prior familiarity with technology to operate the 
device effectively to detect the symptoms of pneumonia 
8 Long operational life in the 
field – e.g. more than two years 
The device (not probes) will have an operational life while being used by 
CHWs of more than 2 years 
9 Does not require charging 
(solar, battery, grid) 
The device does not require charging to be used by CHWs to detect the 
symptoms of pneumonia 
10 Does not require replaceable 
parts  
The device does not require replaceable parts such as non-rechargeable 
batteries and/or consumables throughout its functional life in the field 
11 Requires little or no 
maintenance 
The device does not require any maintenance throughout its operational life 
when used by CHWs to effectively detect the symptoms of pneumonia 
12 High durability/mechanical 
robustness 
The device will not break during normal use by the CHW in the detection of 
the symptoms of pneumonia 
13 
 
High CHW confidence in 
measurements 
The readings provided by the device support the CHW in relation to detecting 
the symptoms of pneumonia 
14 High caregiver acceptability of 
diagnosis 
The readings provided by the device help and support the caregiver/parent in 
accepting the diagnosis offered by the CHW 
15 High patient comfort The device does not cause hurt or discomfort to the patient while being used 
by the CHW in the detection of the symptoms of pneumonia 
16 High portability The device is easy to carry by the CHW during normal working 
17 Easy to maintain hygiene The device is hygienic and easy to maintain in this regard – i.e. doesn’t require 
specialist cleaning procedures or products 
18 Low price (less than $50) The annualized device cost is less than $50 (Device = total package of device 
plus consumables such as batteries/probes and chargers) 
19 High level of safety The device provides a high level of safety when it is being used for the 
detection of the symptoms of pneumonia 
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20. Multi-functional (includes a 
minimum of RR and Pulse 
oximeter) 
The device incorporates several applications for the detection and 
classification of the symptoms of pneumonia 
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